Кардио-и эндотелиопротективное действие макролидных антибиотиков
Диссертация
Материалы работы доложены на итоговых научных сессиях и международных конференциях молодых ученых КГМУ в 2002;2010гг.- VI Международной конференции «Биоантиоксидант» — VIII, XIV Национальных конгрессах «Человек и лекарство» — I, II Национальных конгрессах терапевтовVII съезде аллерголов и иммунологов СНГVI Международной конференции «Клинические исследования лекарственных средств» — II Российской… Читать ещё >
Список литературы
- A.C. RU 2 143 749, МКИЗ С1 6 G09B23/28. Способ изучения хронического септического процесса на лабораторных животных / Р. В. Басанов, И.В. Ярема- Московский мед. стом. ин-т. -№ 98 114 175/14, Бюл. № 4. -14 с.
- Автандилов, Г. Г. Основы патологоанатомической практики / Г. Г. Автандилов. М.: РМАПО, 1994. — 512 с.
- Антибактериальная терапия: практ. рук. / под ред. Л. С. Страчунского, Ю. Б. Белоусова, С. Н. Козлова. М.: Фармединфо, 2002.
- Ариошкова, Е.Б. Влияние антиоксидантов pQ510 и резвератрола на регуляторную функцию эндотелия у крыс с моделированной артериальной гипертонией / Е. Б. Ариошкова // Бюл. эксперим. биологии и медицины. -2007. Т. 143, № 6. — С. 619−622.
- Архипова, М.М. Изучение роли оксида азота в патогенезе сосудистых заболеваний глаз: автореф. дис.. канд. мед. наук / М. М. Архипова. -М., 2000.
- Бабак, О.Я. Артериальная гипертензия и ишемическая болезнь сердца -эндотелиальная дисфункция: современное состояние вопроса / О. Я. Бабак, Ю. Н. Шапошников, В. Д. Немцова // Укр. терапевт, журн. 2004, № 1. — С. 14−21.
- Бакер, Д. Патофизиология гемодинамических нарушений при септическом шоке / Д. Бакер // Morbus. 2008. — № 2. — С. 19−42.
- Белоусов, Ю.Б. Эндотелиальная дисфункция как причина атеросклеротического поражения артерий при артериальнойгипертензии: методы коррекции / Ю. Б. Белоусов, Ж. Н. Намсараев // Фарматека. 2000. — № 6. — С. 62−72.
- Биленко, М.В. Ишемические и реперфузионные повреждения органов / М. В. Биленко. М.: Медицина, 1989. — С. 242−295.
- Булгак, А. А. Вовлечение дисфункции сосудистого эндотелия в патогенез необратимых реперфузионных повреждений миокарда / A.A. Булгак, А. Г. Мрочек, A.B. Гурин // Новости мед.-биол. наук. -2004. № 3. — С. 40−45.
- Ватутин, Н.Т. Инфекция как фактор развития атеросклероза и егоосложнений /Н.Т. Ватутин, В. А. Чупина // Кардиология. 2000. — Vol. 2. 1. Р. 67−71.
- Вихерт, A.M. Ранние ишемические повреждений миокарда при внезапной сердечной смерти / A.M. Вихерт, Н. М. Черпанченко, И. Е. Галахов // Архив патологии.- 1981. Т. 3, № 8. — С. 38−43.
- Власов, Т.Д. Системные нарушения микроциркуляции как следствие органной постишемической реперфузии / Т. Д. Власов // Сб. науч. работ «Патофизиология микроциркуляции» / под ред. H.H. Петрищева. -СПб., 1998.-С. 90−106.
- Галаган, М.Е. Гипотензивное действие оксида азота, продуцируемого из экзо- и эндогенных источников / М. Е. Галаган, A.B. Широколова, А. Ф. Ванин // Вопр. мед. химии. 1991. — Т. 37, № 1. — С. 67−70.
- Гомазков, O.A. Молекулярные и физиологические аспекты эндотелиальной дисфункции. Роль эндогенных химических регуляторов / O.A. Гомазков // Успехи физиол. наук. 2000. — Т. 31, № 4. — С. 48−62.
- Граник, В.Г. Оксид азота (NO). Новый путь к поиску лекарств: монография / В. Г. Граник, Н. Б. Григорьев. М.: Вуз. кн., 2004. — 360 е.:ил.
- Гурбанов, К.К. Сравнительная оценка антиишемического действия верапамила на разных моделях ишемии миокарда / К. К. Гурбанов, Г. В. Ковалев, A.A. Паперно //Фармакол. и токсикол. 1991. — Т.54, № 4. -С. 21−23.
- Драпкина, О.М. Апоптоз кардиомиоцитов и роль ингибиторов АПФ / О. М. Драпкина, A.B. Клименков, В. Т. Ивашкин // Рос. кардиол. журн. -2003.-№ 1.-С. 81−86.
- Задионченко, B.C. Дисфункция эндотелия и артериальная гипертония: терапевтические возможности / B.C. Зодионченко, Т. В. Адашег. а, А. П. Сандомирская // Рус. мед. журн. 2002. — № 1. — С. 11−15.
- Зайцев, A.A. Оптимизация антибиотикотерапии пневмонии / A.A. Зайцев, Ю. Д. Игнатов, О. И. Карпов // Медицина будущего: тез. докл. 1-й науч. конф. — Краснодар, 2002. — С. 47.
- Зотова, И.В. Синтез оксида азота и развитие атеросклероза / И. В. Зотова, Д. А. Затейщиков, Б. А. Сидоренко // Кардиология. 2000. — № 4. — С. 58−67.
- Инфекции и острый инфаркт миокарда: есть ли между ними связь / О. В. Решетников, Ю. П. Никитин, С. К. Малютина и др. // Новости «Вектор-Бест». 2005. — Т. 3. — Р. 37.
- Карпов, О.И. Комплаенс антибиотикотерапии инфекций дыхательных путей у детей / О. И. Карпов // Пульмонология детского возраста: проблемы и решения / под ред. Ю. Л. Мизерницкого, А. Д. Царегородцева М., 2004. — С. 101−107.
- Карпов, О.И. Макролиды: новая парадигма: фармакодинамика/иммуномодуляция / О. И. Карпов // Клинич. фармакология и терапия. 2005. — Т. 14, № 5. — С. 20−23.
- Карпов, О.И. Перспективы применения современных макролидов / О. И. Карпов // Кремлевская медицина. Клинич. вестн. 2005. — № 1. — С. 2328.
- Карпов, О.И. Фармакоэкономика и фармакоэпидемиология средств антибактериальной терапии распространенных инфекций / О. И. Карпов // Фармакоэкономика и фармакоэпидемиология — практика приемлемых решений / под ред. В. Б. Герасимова,
- A.Л. Хохлова, О. И. Карпова. — М.: Медицина, 2005. С. 166−211.
- Киров, М.Ю. Механизмы легочного воспаления при сеспис-индуцированном повреждении легких / М. Ю. Киров, В. В. Кузьков, Э. В. Недашковский // Интенсив, терапия. 2006. — № 1. — С. 22−30.
- Клиническая эффективность лозартана калия и его комбинации с гидрохлортиазидом при гипертонической болезни. Влияние на состояние микроциркуляторного русла / В. И. Подзолков, Е. А. Сон,
- B.А. Булатов, В. И. Маколкин // Кардиология. 2003. — Т. 43, № 11.1. C. 18−22.
- Коган, А.Х. Моделирование инфаркта миокарда: учеб.-метод. пособие для студентов / А. Х. Коган //. М.: МИИ, 1979. — С. 30.
- Коган, А.К. Свободнорадикальные перекисные механизмы патогенеза ишемии и инфаркта миокарда и их фармакологическая регуляция / А. К. Коган, А. Н. Кудрин. М.: Медицина, 1989. — 230 с.
- Короткие курсы азитромицина (су маме да) в лечении осложненных форм острых респираторных заболеваний у детей: пособие для врачей / Ф. С. Харламова и др. — М.: МЗ РФ, 2004. -20 с.
- Красникова, T.JI. Лозартан блокатор ангиотензин II — рецеторов: новое направление в сердечно-сосудистой фармакотерапии / Т. Л. Красникова // Клинич. медицина. — 1996. — № 3. — С. 17−21.
- Кушаковский, М.С. Эссенциальная гипертензия (гипертоническая болезнь). Причины, механизмы, клиника, лечение / М. С. Кушаковский. 5-е изд, доп. и перераб .- СПб.: Фолиант, 2002. — 415 с.
- Лабро, М. Противовоспалительная активность макролидов: новые терапевтические возможности / М. Лабро // Клинич. фармакология и терапия. 1998. — том 7, № 4. — С. 1−14.
- Ланкин, В.З. Антиоксид анты в комплексной терапии атеросклероза: pro et contra / В. З Ланкин, А. К. Тихазе, Ю. Н. Беленков. М.: Медпрактика, 2003. — 200 с.
- Ланкин, В.З. Свободнорадикальные процессы при заболеваниях сердечно-сосудистой системы / В. З. Ланкин, А. К. Тихазе, Ю. Н. Беленков // Кардиология. 2000. — № 7. — С. 48—61.
- Мазуров, В.И. Эндотелиальная дисфункция при метаболическом синдроме / В. И. Мазуров, В. А. Якушева // Эфферентная терапия. -2006.-Т. 12,№ 3. С. 19−24.
- Маколкин, В.И. Артериальная гипертония фактор риска сердечнососудистых заболеваний / В. Г. Граник, Н. Б. Григорьев // Рус. мед. журн. — 2002. — Т. 10, № 19. — С. 862−864.
- Маколкин, В.И. Возможности комбинированной терапии артериальной гипертензии / В. И. Маколкин // ТОП Медицина. — 1998. — № 4. -С. 6−7.
- Малышев, И.Ю. Стресс, адаптация и оксид азота / И. Ю. Малышев, Е. Б. Манухина // Биохимия. 1998. — Т. 63, Вып. 7. — С. 992 — 1006.
- Малышев, И.Ю. Апоптоз и его особенности в эндотелиальных и гладкомышечных клетках сосудов / И. Ю. Малышев,
- Е.А. Монастырская // Дисфункция эндотелия: экспериментальные и клинические исследования. Витебск, 2000. — С. 4−11.
- Марков, Х.М. Молекулярные механизмы дисфункции сосудистого эндотелия / Х. М. Марков // Кардиология. 2005. — Т. 45, № 12. — С. 6268.
- Марков, Х.М. Оксид азота и сердечно-сосудистая система / Х. М. Марков // Успехи физиолог, наук. 2001. — Т. 32, № 3. — С. 49— 65.
- Марков, X. М. Простаноиды и атеросклероз / Х. М. Марков // Патолог, физиология и эксперим. терапия. 2004. — № 1. — С. 2−8.
- Марков, Х.М. Сосудистые эффекты липопротеинов и оксид азота: клеточные и молекулярные механизмы / Х. М. Марков // Патолог, физиология и эксперим. терапия. 2006. — № 3.- С. 2−7.
- Марков, Х.М. Роль оксида азота в патогенезе болезней детского возраста / Х. М. Марков // Рос. вестн. перинатологии и педиатрии. -2000. Т. 45, № 4. — С. 43—47.
- Марков, Х.М. О регуляции деятельности сердца системой Ь-аргинин— оксид азота / Х. М. Марков, С. А. Надирашвили // Патолог, физиология и эксперим. терапия. 2003. — № 4. — С. 9—11.
- Марков, Х.М. Возрастные особенности коронарных эффектов оксида азота / Х. М. Марков, С. А. Надирашвили // Рос. педиатр, журн. 2004. -№ 4.-С. 17—21.
- Марков, Х.М. Оксидантный стресс и дисфункция эндотелия / Х. М. Марков // Патолог, физиология и эксперим. терапия. 2005. -№ 4. — С. 5−9.
- Марков, Х.М. N0 и СО — новый класс сигнальных молекул / Х. М. Марков // Успехи физиолог, наук. 1996. — Т. 27, № 4. — с. 30−43.
- Машковский, М.Д. Лекарственные средства: в 2 т. / М. Д. Машковский.- М.: ООО «Издательство Новая Волна», 2000. -540 с.
- Меерсон, Ф.З. Патогенез и предупреждение стрессорных и ишемических повреждений сердца / Ф. З. Меерсон. М.: Медицина, 1984. — 272 с.
- Меерсон, Ф.З. Предупреждение активации ПОЛ и повреждения антиоксидантных систем миокарда при стрессе и инфаркте / Ф. З. Меерсон, В. Е. Коган, Ю. В. Архипенко // Кардиология. 1981. — № 12. — С. 55−60.
- Меркулов, Г. А. Курс патологогистологической техники / Г. А. Меркулов. Л.: Медицина, 1969. — С. 422.
- Метельская, В.А. Возможности лабораторной оценки NO-продуцирующей функции эндотелия / В. А. Метельская // Клинич. и лаб. диагностика. 2004. — № 9. — С. 86.
- Микроциркуляция в кардиологии / под ред. В. И. Маколкина. -М.: Визарт, 2004. 136 с.
- Моисеев, В.В. Роль воспаления в процессах атерогенеза и в развитии сердечно-сосудистых осложнений / В. В. Моисеев // Врач. 2003. — № 3. — С. 3−6.
- Моисеев, C.B. Антагонисты рецепторов ангиотензина 2: новый подход к лечению гипертонии / C.B. Моисеев // Клинич. фармакология и терапия. 1995. — Т. 4, № 4. — С. 62−64.
- Нарушение продукции NO у мужчин молодого возраста с артериальной гипертензией и немедикаментозный метод ее коррекции / Н. П. Лямина, В. П. Сенгихин, Д. А. Подкидышев, Е. Б. Манухина // Кардиология. 2001. — № 9. — С. 17−21.
- Небиеридзе, Д.В. Микроциркуляторные расстройства при артериальной гипертонии и перспективы их коррекции / Д. В. Небиеридзе, Е. В. Шилова, С. Н. Толпыгина // Кардиоваскуляр. терапия и профилактика. 2004. — № 4. — С. 28−32.
- Некрутенко, Л.А. Дисфункция эндотелия и возможности её коррекции индапамидом-ретард у больных артериальной гипертензией пожилого возраста / JI.A. Некрутенко, А. В. Агафонов, Д. А. Лыкова // Артериальная гипертензия. 2004. — Т. 10, № 1. — С. 21−24.
- Никитин, А.В. Направления адьювантной патогенетической терапии инфекционных и аутоиммунных заболеваний / А. В. Никитин // Антибиотики и химиотерапия. 2004. — № 8. — С. 4956.
- Оганов, Р.Г. Метаболические эффекты блокаторов рецепторов ангиотензина II / Р. Г. Оганов, А. В. Небиеридзе // Кардиология. 2002. -Т. 42, № 3.-С. 35−39.
- Ольбинская, Л.И. Блокаторы рецепторов ангиотензина II при лечении артериальной гипертонии / Л. И. Ольбинская // CONSILIUM MEDICUM (прил.). 2005. — № 2. — С. 27−28.
- Ольбинская, Л.И. Эндотелиновая агрессия в патогенезе хронической сердечной недостаточности и подходы к её терапевтической коррекции / Л. И. Ольбинская, Ю. И. Найманн // Терапевт, арх. 2005. — № 9. — С. 88−93.
- Пашин, Е.Н. Кардиопротективное действие эмоксипина на модели гипоксия-реоксигенация / Е. Н. Пашин // Актуальные вопросыэкспериментальной и клинической медицины и фармации: материалы конф. / КГМУ. Курск, 1993. — С. 171.
- Перспективы медикаментозного лечения эндотелиальной дисфункции / Г. А. Романовская, Е. В. Акатова, Г. Н. Гороховская и др. // Фарматека. -2006. № 9. — С. 50−56.
- Петрищев, H.H. Физиология и патофизиология эндотелия / H.H. Петрищев, Т. Д. Власов // Дисфункция эндотелия. Причины, механизмы. Фармакологическая коррекция. СПб.: СПб ГМУ, 2003. -С. 4−38.
- Петухов, В.А. Дисбиоз, эндотоксиновая агрессия, нарушение функций печени и дисфункция эндотелия в хирургии. Современный взгляд на проблему / В. А. Петухов // Трудный пациент. 2006. — № 4. — С. 20−29.
- Петухов, В.А. Современный взгляд на проблему эндотоксиновой агрессии и дисфункции эндотелия в хирургии / В. А. Петухов // Хирургия. 2008. — № 2. — С. 37−49.
- Пичугин, В.В. Биохимические и функциональные аспекты экспериментальной терапии расстройств кровоснабжения и биоэнергетики миокарда в острой стадии регионарной ишемии сердца : автореф. дис. д-ра мед. наук / В. В. Пичугин. М., 1979. — 25 с.
- Покровский, В.И. Оксид азота, его физиологические и патофизиологические свойства / В. И. Покровский, H.A. Виноградов // Терапевт, арх. 2005. — № 1. — С. 82−87.
- Поливода, С.Н. Фактор Виллебранда как маркер эндотелиальной дисфункции у пациентов с заболеваниями сердечно-сосудистой системы / С. Н. Поливода, A.A. Черепок // Укр. ревмат. журн. 2000. -№ 1.-С. 13−17.
- Применение дибунола для стимуляции репаративных процессов в сердечной мышце при инфаркте миокарда у крыс / В. В. Пичугин, JI.A. Конорев, В. Ю. Полумисков, В. А. Карев // Фармакология и токсикология. 1989. — Т. 52, № 6. — С. 52−56.
- Продукция и депонирование оксида азота при адаптации к гипоксии / Е. Б. Манухина, И. Ю. Малышев, Б. В. Смирин и др. // Изв. АН. Сер. Биология. 1999. — № 2. — С. 211−215.
- Противоишемический и кардиопротективный эффект мексидола / В. В. Гацура, В. В. Пичугин, JI.H. Сернов, Л. Д. Смирнов // Кардиология. 1996.-№ 1.-С. 59−62.
- Роль дисфункции эндотелия в развитии ишемии миокарда у больных ишемической болезнью сердца с неизменёнными и малоизменёнными коронарными артериями / В. Б. Сергиенко, Е. В. Саютина, Л. Е. Самойленко и др. // Кардиология. 1999. — Т. 39, № 1. — С. 25−30.
- Руднов, В.А. Сепсис: современный взгляд на проблему / В. А. Руднов // Антибиотики и химиотерапия. 2000. — № 7. — С. 3−7.
- Рудык, Ю.С. К вопросу о связи инфекции с атеросклерозом / Ю. С. Рудык // Здоров"я Украши. 2004. — № 94−96.
- Сепсис в начале XXI века. Классификация, клинико-диагностическая концепция и лечение. Патолога анатомическая диагностика: практ. рук. / под ред. B.C. Савельева. — М.: НЦССХ им. А. Н. Бакулева РАМН, 2004. — С. 634.
- Страчунский, Л.С. Макролиды в современной клинической практике / Л. С. Страчунский, С. Н. Козлов.- Смоленск: Русич', 1998.243 с.
- Страчунский, Л.С. Современная антимикробная химиотерапия: рук. для врачей / Л. С. Страчунский, С. Н. Козлов. -М.: Боргес, 2002.
- Терещенко, С.Н. Бета-блокаторы у больных с относительными противопоказаниями к их применению / С. Н. Терещенко // Сердечная недостаточность. 2003. — Т. 4, № 1(17). — С. 55−56.
- Тишкин, С.М. Функциональное состояние адренореактивности миокарда при экспериментальном кардиосклерозе / С. М. Тишкин, В. М Тараненко, Н. В. Талаева // Патолог, физиология и эксперим. терапия. 1990. — Т. 25, № 5. — С. 15−17.
- Функциональное состояние эндотелия у больных артериальной гипертонией и ишемической болезнью сердца / Д. А. Затейщиков, JI.O. Минушкина, О. Н. Кудряшова и др. // Кардиология. 2000. — Т.40, № 6. -С. 14−17.
- Хабриев, Р.У. Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ. Р. У. Хабриев. М.: Медицина, 2005. — 832 с.
- Характеристика биохимических маркеров функции сосудистого эндотелия: разработка модельной системы с применением клеточных культур / В. А. Метельская, Н. Г. Туманова, O.A. Литинская и др. // Вопр. биол. медицины и фарм. химии. 2004. — № 2. — С. 34−39.
- Ходосовский, М.Н. К механизму протекторного влияния L-аргинина на печень при ишемии-реперфузии / М. Н. Ходосовский // Эксперим. и клинич. фармакология. 2006. — Т. 69, № 3.- С. 40−42.
- Шестакова, М.В. Дисфункция эндотелия причина или следствие метаболического синдрома / М. В. Шестакова // РМЖ. — 2001. — Т. 9, № 2. — С. 88.
- Шляхто, Е.В. Клеточные аспекты ремоделирования сосудов при артериальной гипертензии / Е. В. Шляхто, О. М. Моисеева // Артериальная гипертензия. 2002. — Т. 8, № 2. — С. 45−49.
- A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis/ B. Wallwork, W. Coman, A. Mackay-Sim et al. / /Laryngoscope. 2006. — Vol. 116 (2),-P. 189−93.
- A macrolide antibiotic, roxythromycin, inhibits the growth of human myeloid leukemia HL60 cells by producing multinucleate cells/ M. Nagai, H. Yamada, S. Nakada et al. // Molecular Cell. Biochem. 1995. — Vol. 144, -P. 191−195.
- A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis / T. Kadota, O. Sakito, S. Kohno et al. //Am. Rev. Respir. Dis. 1993. — Vol. 147. — P. 153−159.
- A review of guidelines and a multidisciplinary consensus statement from the National Stroke Assotiation / P.B. Gorelick, R.L. Sacco, D.B. Smith et al.//JAMA.- 1999. Vol. 31. — P. 1112−1120.
- A review of macrolide treatment of atherosclerosis and abdominal aortic aneurysms / J.S. Lindholt, J. Stovring, P.L. Andersen et al. // Curr. Drug. Targets Infect. Disord. 2003. — Vol. 3, N 1. — P. 55−63.
- Abnormal tissue oxygenation and cardiovascular changes in endotoxemia / P.B. Anning, M. Sair, C. Peter Winlove et al. // Am. J. Respir. Crit. Care. Med. 1999.-Vol. 159.-P. 1710−1715.
- Acute brain cytokine responses after global birth hypoxia in the rat / H. Ashdown, S. Joita, G.N. Luheshi, P. Boksa // J. Neurosci. Res. 2008. -Jul 14. — P. 345−349.
- Acute respiratory-tract infections and risk of first-time acute myocardial infarction / C.R. Meier, S.S. Jick, L.E. Derby et al. // Lancet. -1998.-Vol. 351.-P. 1467−1471.
- Acute systemic inflammation impairs endothelium dependent dilatation in humans // Circulation. — 2000. — № 102. — P. 994 — 999.
- Adak, S. Arginine conversion to nitroxide by tetrahydrobiopterin-free neuronal nitric-oxide synthase / S. Adak, Q. Wang, D.J. Stuehr // J. Biol. Chem. 2000. — Vol. 275. — P. 33 554−33 561.
- Adhikari, S. Catalase activity of oxygenase domain of rat neuronal nitric oxide synthase. Evidence for product formation from L-arginine / S. Adhikari, S. Ray, R. Gachhui // FEBS Lett. 2000. — Vol. 475. — P. 35−38.
- Ageing-associated endothelial dysfunction in humans / A. Chauhan, S. More, P.A. Mullins et al. // J. Am. Col. Cardiol. -1996. Vol. 28. — P. 1796 -1804.
- Agen, C.R. Macrolide antibiotics as anti-inflammatory agents: roxithromycin in an unexpected role / C. Agen, R. Danesi, C. Blandizzi et al. // Agents Action. 1993. — № 38. — P. 85−90.
- Akerman, K.K. Scanning Electron Microscopy of Nanobacteria -Novel Biofilm Producing Organisms in Blood / K.K. Akerman, I. Kuronen, E.O. Kajander // Scan. El. Microscopy. 1993. — Vol. 15, Suppl. III. -P. 90−91.
- Alctan, B. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion / B. Aktan,
- S. Taysi, K. Gumu§ tekin // Pol. J. Pharmacol. 2003. — Vol. 55, № 6. -P. 1105−1110.
- Alain, T. Anti-Inflammatory Mechanisms in the Vascular Wall / T. Alain, M. Ziad // Circulation Research. 2001. — Vol. 88. — P. 877.
- Alderton, W. K. Nitric oxide synthases: structure, function and inhibition / W. K. Alderton, C. E. Cooper, R. G. Knowles // Biochem. J. -2001.-Vol. 357.-P. 593−615.
- Alison, B. Nitric oxide regulation of free radical and enzymemediated lipid and lipoprotein oxidation / B. Alison // Ateriosclerosis, Thrombosis and Vase. Biol. 2000. — Vol. 20, № 7. -P. 1707−1715.
- Alterations of host response by long-term treatment of roxithromycin / E. Kita, M. Sawaki, K. Mikasa et al. // J. Antimicrob. Chemother. 1993. — Vol. 32. — P. 285−294.
- Alternative hypothesis for efficacy of macrolides in acute coronary syndromes / D. Martin, J. Bursill, M.R. Qui et al. // Lancet. 1998. — Vol. 351.-P. 1858−1859.
- An experimental study on the effect of azithromycin treatment in bleomycin-induced pulmonary fibrosis of rats / J. Chen, B. He, Y. Li et al. // ZhonghuaNei Ke Za Zhi. 1999. — Oct. 38(10). — P. 677−680.
- Anderson, H.D. Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells / H.D. Anderson, D. Rahmutula, D.G. Gardner // J. Biol. Chem. 2004. — Vol. 279. — P. 963−969.
- Anderson, J.L. Antibiotic trials for coronary heart disease / J.L. Anderson, J.B. Muhlestein // Tex. Heart. Inst. J. 2004. — Vol. 31, № 1.-P. 33−38.
- Anderson, J.L. Azithromycin in patients with coronary artery disease / J.L. Anderson // Circulation. 1998. — Vol. 31, № 39(11). — P. 1240−1248.
- Anderson, R. Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils / R. Anderson, A.J. Theron, C. Feldman // Inflammation. 1996. — Vol. 20, № 6. — P. 693−705.
- Andraws, R. Effects of Antibiotic Therapy on Outcomes of Patients With Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials / R. Andraws, J.S. Berger, D.L. Brown // JAMA. 2005. — Vol. 293, № 21.-P. 2641−2647.
- Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis / F. Lovren, Y. Pan, A. Quan et al. // Am. J. Physiol. Heart. Circ. Physiol. 2008. — Vol. 295, № 4. — P. H1377 — H1384.
- Angiotensin II stimulates NADH and NADH oxidase activity in cultured vascular smooth muscle cells / K.K. Griendling, C.A. Minieri, J.D. Ollerenshaw, R.W. Alexander // Circ. Res. 1994. — Vol. 74. -P. 1141−1148.
- Ankle-brachial pressure index: a simple tool for assessing cardiovascular risk in patients with systemic vasculitis / S.R. Sangle, R.J. Davies, M. Mora et al. // Rheumatology. 2008. — Vol. 47, № 7. -P. 1058−1060.
- Anti-allergic activity of roxithromycin: inhibition of interleukin-5 production from mouse T lymphocytes / S. Konno et al. // Life Sciences. 1993. — Vol. 52. — P. 25−30.
- Antiangiogenetic and antitumor effects of 14-membered ring macrolides on mouse B16 melanoma cells / J. Yatsunami, Y. Fukuno, M. Nagata et al. // Clin. Exp. Metastasis. 1999. — Vol. 17. — P. 361 367.
- Antiasthmatic activity of a macrolide antibiotic roxythromycin: analysis of possible mechanisms in vitro and in vivo / S. Konno, K. Asano, M. Kurukawa et al. // Int. Arch. All. Immunol. 1994. — Vol. 105.-P. 308−316.
- Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome / C. Cannon, E. Braunwald, C. McCabe et al. // N. Engl. J. Med. -2005.-Vol. 352.-P. 1646−1654.
- Antibiotic-induced apoptosis in human activated peripheral lymphocytes / J. Kadota, S. Mizunoe, K. Kishi et al. // Int. J. Antimicrob. Agents. -2005. Vol. 25, № 3. — P. 216−220.
- Antibiotics and risk of subsequent first-time acute myocardial infarction / C. Meier, L. Derby, S. Jick et al. // JAMA. 1999. — Vol. 281. -P. 427−431.
- Anti-inflammatory actions of macrolides: potential for preventing lung damage in cystic fibrosis. 3rd Int. Conf. on the Macrolides, Azalides and Streptogramins / S. Brennan, P. Isly, M. Everard et al. // Lisbon. 1996. -P. 75.
- Anti-inflammatory activity of macrolide antibiotics / A. Ianaro, A. Ialenti, P. Maffia et al. // J. Pharmacol. Exp. Ther. 2000. — Vol. 292. -P. 156−163.
- Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease / A.L. Pukhalsky, G.V. Shmarina, N.I. Kapranov et al. // Med. Inflamm. 2004. — Vol. 13. -P. 111−117.
- Antineutrophil cytoplasm antibody-induced neutrophil nitric oxide production is nitric oxide synthase-independent / W.Y. Tse, J. Williams, A. Pall et al. // Kidney Int. 2001. — Vol. 59. — P. 593−600.
- Aoshiba, K. Erythromycin shortens neutrophil survival by accelerating apoptosis / K. Aoshiba, A. Nagai, K. Konno // Antimicrob. Ag. Chemother. 1995. — Vol. 39. — P. 872−877.
- Apoptosis, oxidative metabolism and interleukin-8 production in human neutrophils exposed to azithromycin: effects of Streptococcus pneumoniae / C.C. Koch, D.J. Esteban, A.C. Chin et al. // J. Antimicrob. Chemother. 2000. — Vol. 46, № 1. — P. 19−26.
- Armitage, G.C. Basic features of biofilms why are they difficult therapeutic targets? / G.C. Armitage // Ann. R. Australas. Coll. Dent. Surg. -2004.-Vol. 17.-P. 30−34.
- Arterial Intima-Media Thickness in 13-Year-Old Adolescents and Previous Antichlamydial Antimicrobial Use: A Retrospective Follow-up Study / I. Volanen, K. Kallio, M. Saarinen et al. // Pediatrics. 2008. — Vol. 122.-P. e675-e681.
- Association between periodontal disease and acute myocardial infarction / G. Emingil, E. Buduneli, A. Aliyev et al. // J. Periodontol. -2000.-Vol. 71, N 12.-P. 1882−1886.
- Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy / Y.F. Zhou, B.L. Martin, A.W. Myron et al. // New Engl. J. Med. 1996. — Vol. 335. — P. 624−630.
- Associatiort analysis of CA repeat polymorphism of the endothelial nitric synthase gene to essential hypertension in Japanese / T. Nakayma, J. Soma, J. Takahashi el al. // Clin. Genet. 1997. — Vol. 51. — P. 26−30.
- Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia / R.N. Boger, S.M. Bode-Boger, A. Szuba et al. // Circulation. 1998. — Vol. 98. — P. 1842— 1847.
- Atherosclerosis 2005: Recent Discoveries and Novel Hypotheses / P.J. Goldschmidt-Clermont, M.A. Creager, D.W. Lorsordo et al. // Circulation. 2005. — Vol. 112, N 21. — P. 3348−3353.
- Attenuation of endotoxin-induced multiple organ dysfunction by l-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase / H. Ruetten, G.J. Southan, A. Abate et al. // Br. J. Pharmacol. 1996. — Vol. 118.-P. 261−270.
- Azithromycin causes an accumulation of lipids in lysosomes of cultured cells: biochemical mechanism and potential relationship with its long time retention in cell / J.P. Montenez, F. Van Bambeke, iL
- M.P. Mingeot-Leclercg et al. // The 36 Interscience Conference on Antimicrobial Agents and Chemotherapy, abstr. New Orleans, 1996. — P. 85.
- Azithromycin for the secondary prevention of coronary artery disease events. The WIZARD study: a randomized controlled trial / M.C. O’Connor, M.W. Dunne, M.A. Pfeffer et al. // JAMA. 2003. — Vol. 290. — P. 14 591 466.
- Azithromycin for the secondary prevention of coronary events / J. Grayston, R. Kronmal, L. Jackson et al. // N. Engl. J. Med. 2005. -Vol. 352.-P. 1637−1645.
- Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects / O. Culic, V. Erakovic, I. Cepelak et al. // Eur. J. Pharmacol. 2002. — Vol. 450. — P. 277−289.
- Bakar, O. The effect of azithromycin on reactive oxygen species in rosacea / O. Bakar, Z. Demirsay, M. Yuksel // Clin. Exp. Dermatol. 2007. -Vol. 32, № 2.-P. 197−200.
- Baker, W.L. Azithromycin for the secondary prevention of coronary artery disease: A meta-analysis / W.L. Baker, K.A. Couch // Am. J. Health. Syst. Pharm. 2007. — Vol. 64. — P. 830−836.
- Barbato, J.E. Nitric oxide and arterial disease / J.E. Barbato, E. Tzeng // J. Vase. Surg. 2004. — Vol. 40. — P. 187−193.
- Barron, J.T. Energetic effects of adenosine on vascular smooth muscle / J.T. Barron, L. Gu // Am. J. Physiol. Heart. Circ. Physiol. 2000. — Vol. 278, № l.-P. 26−32.
- Basyigit, I. The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data / I. Basyigit, F. Yildiz, S.K. Ozkara // Ann. Pharmacother. 2004. -Vol. 38. — P. 1400−1405.
- Bates, E. Eicosanoids, fatty acids and neutrophils: their relevance to the pathophysiology of disease / E. Bates //Prostaglandins, Leukotriens and Essential Fatty Acids. 1995. — Vol. 53. — P. 75−86.
- Baumann, H. The acute phase response / H. Baumann, J. Gauldie // Immunology Today. 1994. — Vol. 15. — P. 74−80.
- Bautista, L.E. Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence / L.E. Bautista // J. Hum. Hypertens. 2003. — Vol. 17(4). — P. 223−230.
- Benditt, E.P. Viruses in the citology of atherosclerosis / E.P. Benditt, T. Barret, J.K. McDougall // Proc. Natl. Acad. Sci. USA. 1983. — Vol. 80. -P. 6386−6389.
- Beneficial effect of antioxidants and L-arginine on oxidant-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress / F. Nigris, L.O. Lerman, S.W. Ignarro et al. // PNAS. 2003. -Vol. 100.-P. 1420−1425.
- Beneficial effect of tetrahydrobiopterin on ischemia-reperfusion injury in isolated perfused rat hearts / S. Yamashiro, K. Noguchi, T. Matsusaki et al. // J. Thorac. Cardiovascular. Surg. 2002. — Vol. 124, № 4. p. 775— 784.
- Berk, B.C. Atheroprotective signaling mechanisms activated by steady laminar flow in endothelial cells / B.C. Berk // Circulation. 2008. -Vol. 117, № 8.-P. 1082−1089.
- Berman, M. Ex-vivo effect of roxithromycin on human and rat arterial vasoactivity / M. Berman, D. Hasdai, E. Raanani // Interactive Cardio Vascular and Thoracic Surgery. 2005. — Vol. 4, № 3. — P. 232−237.
- Bhagat, K. Endothelial «stunning» following a brief exposure to endotoxin: a mechanism to link infection and infarction? / K. Bhagat, R. Moss, J. Collier // Cardiovasc Res. 1996. — Vol. 32. — P. 822−829.
- Bhagat, K. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo / K. Bhagat, P. Vallance // Circulation. 1997. -Vol. 96. — P. 3042−3047.
- Bian, K. Vascular system: role of nitric oxide in cardiovascular diseases / K. Bian // J. Clin. Hypertens. (Greenwich). 2008. — Vol. 10, № 4. -P. 304−310.
- Binet, R. Fitness Cost Due to Mutations in the 16S rRNA Associated with Spectinomycin Resistance in Chlamydia psittaci 6BC / R. Binet, A.T. Maurelli // Antimicrob. Agents Chemother. 2005. — Vol. 49. -P. 4455−4464.
- Biyskier. A. New medical targets for macrolides. Expert Opinion Invest / A. Biyskier, C. Agouridas, J. Chantot //Drags. 1994. — Vol. 3. — P. 405−410.
- Blake, G.J. C-Reactive protein and other inflammatory risk markers in acute coronary syndromes / G.J. Blake, P.M. Ridker // J. Am. Coll. Cardiol. -2003.-Vol. 41.-P. 37−42.
- Blood flow regulates the development of vascular hypertrophy, smooth muscle cell proliferation, and endothelial cell nitric oxide synthase in hypertension / H. Ueno, P. Kanellakis, A. Agrotis, A. Bobik // Hypertension. 2000.-Vol. 36 — P. 89.
- Bonetti, P.O. Endothelial dysfunction. A marker of atherosclerotic risk / P.O. Bonetti, L.O. Lerman, A. Lerman // Arterioscler. Thromb. Vase. Biol. -2003.-Vol. 23.-P. 168−175.
- Bosnar, M. Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived GM-CSF and IL-l? / M. Bosnar // JPET Fast Forward. 2009. — July DOI, № 10. — P. l 124.
- Bouwman, J.J. Azithromycin reduces Chlamydia pneumoniae-induced attenuation of eNOS and cGMP production by endothelial cells / J.J. Bouwman, F.L. Visseren, L.M. Bevers // Eur. J. Clin. Invest. 2005. — Vol. 35, № 9. — P. 573−582.
- Bozovich, G.E. Chlamydia pneumoniae: more than a bystander in acute coronary syndromes / G.E. Bozovich, E.P. Gurfinkel // Br. J. Cardiol. -1998.-Vol. 5.-P. 84−90.
- Bradley, J.S. Pharmacodynamics and the prediction of efficacy in short-course antibiotic therapy: pediatric studies to validate the model / J.S. Bradley // Pharmacotherapy. — 2005. — Vol. 12, Pt 2. — P. 159S-164S.
- Brandes, R.P. And what about the endothelium? On the predominance of cerebral superoxide formation for angiotensin II-induced systemic hypertension / R.P. Brandes // Circ. Res. 2004. — Vol. 95, № 2. — P. 122 124.
- Braunwald, E. Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities / E. Braunwald // N. Engl. J. Med. 1997. — Vol. 337, № 19. — P. 1360−1369.
- Bryskier, A. Newer macrolides and their potential target organisms / A. Bryskier// Curr. Opinion Inf. Dis. 1992. — Vol. 5.-P. 764−772.
- Bryskier, A. New insights into the structure-activity relationship of macrolides and azalides. In: New Macrolides, Azalides, and Streptogramins in Clinical Practice / A. Bryskier, C. Agouridas, J.F. Chantot. New York, etc., 1995.-P. 3−30.
- Bryskier, A. Macrolides. New therapeutic prospects / A. Bryskier, M.T. Labro // Prese Med .- 1994.- Vol. 23, № 38.- P. 1762−1766.
- Bryskier, A.C. Macrolide antibiotics and the heart / A.C. Bryskier, V. Agouridas // Expert. Opinion Invest Drugs. -1994.-Vol. 3.-P. 1213 1219.
- Burgner, D. Nitric oxide and infectious diseases / D. Burgner, K. Rockett, D. Kwiatkowski //Arch. Dis. Child. 1999. — Vol. 8, N 2. — P. 185−189.
- Byrne, G.I. Chlamydia pneumoniae and atherosclerosis: Links to the disease process / G.I. Byrne, M.V. Kalayoglu // Am. Heart J. 1999. — Nov. 138(5 Pt 2). — P. 488−490.
- Carbon, C. Clinical relevance of intracellular and extracellular concentrations of macrolides / C. Carbon // Infection. 1995. — Vol. 23 (suppl. 1).-P. 10−14.
- Cardiac angiotensin II receptors are upregulated by long-term inhibition of nitric oxide synthesis in rats / M. Katoh, K. Egashira, M. Usui et al. // Circ. Res. 1998. — Vol. 83. — P. 743−751.
- Cardiovascular lipid accumulation with Coxsackie B virus infection in mice / N.G. Ilback, A. Mohammed, J. Fohlman, G. Friman // Am. J. Pathol. 1990.-Vol. 136, N 1.-P. 159−167.
- Carevic, O. Comparative studies on the effects of erymromycin A and azithromycin upon extracellular release of lysosomal enzymes in inflammatory processes / O. Carevic, S. Djokic // Agents Actions. 1998. -Vol. 25, № 1−2.-P. 124−131.
- Carlisle, S.S. Chlamydia pneumoniae and coronary heart disease / S.S. Carlisle // Ann. Pharmacother. 1999. — Vol. 33, № 5. — P.615−622.
- Caspase activation and mitochondrial cytochrome C release during hypoxia-mediated apoptosis of adult ventricular myocytes / D. De Moissac, R. Guervich, H. Zheng et al. // J. Mol. Cell. Cardiol. 2000. — Vol. 32. -P. 53−63.
- Cavelin, caveolae and endothelium cell function / P.O. Frank, S.E. Woodman, D.S. Park, M.P. Lisanii // Arterioscler. Thromb. Vase. Biol. -2003.-Vol. 23.-P. 1161−1168.
- Cazzola, M. Matera, Macrolide and occult infection in asthma / M. Cazzola//Medicine. 2004. — Vol. 10, Issue 1. — P. 7−14.
- Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin / M. Bosnar, Z. Kelneric, V. Munic et al. // Antimicrob. Agents. Chemother. 2005. — Vol. 49, № 6. -P. 2372−2377.
- Cervin, A. Effects of long-term clarithromycin treatment on lavage-fluid markers of inflammation in chronic rhinosinusitis / A. Cervin // Clinical Physiology & Functional Imaging. 2009. — Vol. 29, № 2. — P. 136 142.
- Chan, N.N. Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population / N.N. Chan, H.M. Colhoun, P. Vallance // J. Am. Coll. Cardiol. 2001. — Vol. 38. — P. 1814−1820.
- Channon, K.M. Nitric oxide synthase in atherosclerosis and vascular injury. Insights from experimental gene therapy / K.M. Channon, U.S. Qian, S.E. George // Arterioscler. Tromb. Vase. Biol. 2000. — Vol. 20. -P. 1873—1891.
- Chen, X. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR / X. Chen, R.M. Touyz, J.B. Park // Hypertension. 2001. -Vol. 38.-P. 606−611.
- Chiu, J.J. Vascular endothelial responses to altered shear stress: Pathologic implications for atherosclerosis / J.J. Chiu, S. Usami, S. Chien // Ann. Med. 2008. — Vol. 18. — P. 1−10.
- Chiu, B. Multiple infections in carotid atherosclerotic plaques / B. Chiu//Am. Heart J. 1999. -Nov. 138 (5 Pt 2). — P. 534−536.
- Chlamydia Infections and Heart Disease Linked Through Antigenic Mimicry / K. Bachmaier, N. Neu, L.M. de la Maza et al. // Science. 1999. -Feb. 26, Vol. 283 (5406). — P. 1335−1339.
- Chlamydia pneumoniae (TWAR) / C.C. Kuo, L.A. Jackson, L.A. Campbell et al. // Clin. Microbiol. Rev. 1995. — Vol. 8. — P. 451−461.
- Chlamydia pneumoniae (TWAR) and atherosclerosis (abstract) / J.T. Grayston, D.H. Thom, C.C. Kuo et al. // Chlamydial infections / eds. J. Orfila, G. Byrne, M.A. Chernesky. Bologna: Societa Editrice Esculapio, 1994.
- Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery / J.T. Grayston, C.C. Kuo, A.S. Coulson et al. // Circulation. 1995. -Vol. 92.-P. 3397−3400.
- Chlamydia pneumoniae and vascular disease: an update / F.F. Mussa, H. Chai, X. Wang et al. // J. Vase. Surg. 2006. — Vol. 43, N 6. — P. 13 011 307.
- Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profile / L.J. Murray, D.P. 0"Reilly, G.M. Ong et al. // Heart. J. -1999. Vol. 81, № 3. — P. 239−244.
- Chlamydia pneumoniae infection in human monocytes / S. Airenne, H.M. Surcel, H. Alakarppa et al. // Infect. Immun. 2000. — Mar 67, № 3. -P. 1445−1449.
- Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months / L. Liu, H. Hu et al. // Mol. Cell. Biochem. 2000. — Vol. 215, №> 1−2. — P. 123−128.
- Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research / M.D. de Kruif, E.C. van Gorp, T. T Keller et al. // Cardiovasc. Res. 2005. — Vol. 65, N 2. — P. 317−327.
- Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease (abstract) / M.A. Mendall, D. Carrington, D. Strachan et al. // J. Infect. Dis. 1995. — Vol. 30. — P. 121−128.
- Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study / P. Saikku, M. Leinonen, L. Tenkanen et al. // Ann. Intern. Med. 1992. — Vol. 116. — P. 273−278.
- Chronic Chlamydia pneumoniae infection is associated a serum lipid profile known to be a risk factor for atherosclerosis / A. Laurila, A. Bloigu, S. Nayha et al. // Arterioscler. Thromb. Vase. Biol. 1997. — Vol. 17. -P 2910−2913.
- Chronic exercise in dogs increases coronary vascular NO production and endothelial NOS-gene expression / W.S. Sessa, K. Prichard, N. Seyedi et al. // J. Clin. Investig. 1992. — Vol. 90. — P. 278—281.
- Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II / S. Kitamoto, K. Egashira, C. Kataoka et al. // J. Hypertens. 2000. -Vol. 18. — P. 1795 — 1800.
- Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats / H. Matsuoka, M. Nakata, K. Kohno et al. // Hypertension. 1996. — Vol. 27. — P. 14−18.
- Chronic NOS inhibition actuates endothelial-mesenchymal transformation / E. O’Riordan, N. Mendelev, S. Patschan et al. // Am. J. Physiol. Heart. Circ. Physiol. 2007. — Vol. 292, № 1. — P. H285 — H294.
- Churchill, E.N. The roles of PKCdelta and epsilon isoenzymes in the regulation of myocardial ischaemia/reperfusion injury / E.N. Churchill, D. Mochly-Rosen // Biochem. Soc. Trans. 2007. — Vol. 35, Pt. 5. — P. 10 401 042.
- Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease / S. Xiao, L. Wagner, R.J. Schmidt, C. Baylis // Kidney. Int. 2001. — Vol. 59. — P. 1466−1472.
- Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study / J.D. Spahn, D.A. Fost, R. Covar et al. // Ann. Allergy. Asthma. Immunol. 2001. — Vol. 87. — P. 501−505.
- Clarithromycin supresses bronchial hyperresponivennes associated with eosinophilic inflammation in patient with asthma / H. Amayasu, S. Yoshida, S. Ebana et al. // Annals Allergy Asthma Immunol. 2000. -Vol. 84. — P. 594−598.
- Clinical aspects of reactive oxygen and nitrogen species / A. Warnholtz, M. Wendt, M. August, T. Miinzel // Biochem. Soc. Symp. -2004.-Vol. 71.-P. 121−133.
- Conformed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis / M. Davidson, C.C. Kuo, J.P. Middaugh et al. // Circulation. 1998. — Vol. 98. — P. 628−633.
- Cooke, J.P. Flow, NO and atherogenesis / J.P. Cooke // PNAS. 2003. -Vol. 100, № 3.-P. 768—770.
- Cooke, J.P. Nitric oxide and angiogenesis / J.P. Cooke, D.W. Losordo // Circulation. 2002. — Vol. 105. — P. 2133−2138.
- Coombes, B.K. cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection / B.K. Coombes, J.B. Mahony // Infect. Immun. 2001. — Vol. 69, № 3. -P. 1420−1427.
- Coronary endothelial dysfunction after ischemia and reperfusion and its prevention by ischemic preconditioning / P. Pagliaro, A. Chiribiri, D. Mancardi et. al. // Ital. Heart J.- 2003.- Vol. 4, № 6.- P. 383−394.
- C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease / J. Danesh, J.G. Wheeler, G.M. Hirschfield et al. // N. Engl. J. Med. 2004. — Vol. 350. — P. 13 871 397.
- C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor / J. Cermak, N.S. Key, R.R. Bach et al. // Blood. -1993.-Vol. 82.-P. 513−520.
- Culic, O. Anti-inflammatory effects of macrolide antibiotics / O. Culic, V. Erakovic, M.J. Parnham // Eur. J. Pharmacol. 2001. — Vol. 429.-P. 209−229.
- Cutaneously applied erythromycin base reduces various types of inflammatory reaction in mouse ear / J.P. Tarayre, M. Aliaga, M. Barbara et al. // Int. J. Tissue React. 1987. — Vol. 9. — P. 77−85.
- Dalziel, K. The effect of tetracycline and erythromycin in a model of acne-type inflammation/ K. Dalziel, P. Dykes, R. Marks // Br. J. Exp. Pathol. 1987. — Vol. 68. — P. 67−70.
- Danesh, J. Chronic infections and coronary heart disease: is there a link? / J. Danesh, R. Collins, R. Peto // Lancet. 1997. — Vol. 350. — P. 430 436.
- Danesh, J. Persistent infection and vascular disease: A systemic rewiew (abstract) / J. Danesh, P. Appleby // Expert Opinion on Investigational Drugs. 1998. — Vol. 7. — P. 691−713.
- Das, M. Molecular mechanism of preconditioning / M. Das, D.K. Das // IUBMB Life. 2008. — Vol. 60, № 4. p. 199−203.
- Davies, D. Understanding biofilm resistance to antibacterial agents / D. Davies //Nat. Rev. Drug. Discov. 2003. — Vol. 2, N 2. — P. 114−122.
- Davignon, J. Role of endothelial dysfunction in atherosclerosis / J. Davignon, P. Ganz // Circulation. 2004. — Vol. 109. — P. III-27-III-32.
- De Keuleaner, D.C. Macrolides / D.C. De Keuleaner, N. Chappell, R. Ishikawa // Circ. Res. 1998. — Vol. 82. — P. 10 941 101.
- De novo induction of atherosclerosis by chlamydia pneumoniae in a rabbit model / I.W. Fong, B. Chiu, E. Viira et al. // Infect. Immun. 1999. -Vol. 67, № 11. — P. 6048−6055.
- Dean, D. Molecular and biological characterization of a unique isolate of chlamydia pneumonia from a coronary atheroma / D. Dean, R. Molestina // Abstracts of Proceedings of the 3rd Meeting of the European Society for Chlamydial Research. P. 43.
- Demmer, R.T. Periodontal infections and cardiovascular disease: The heart of the matter / R.T. Demmer, M. Desvarieux // J. Am. Dent. Assoc. -2006.-Vol. 137.-P. 14S-20S.
- Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells / S.K. Venugopal, S. Devaraj, I. Yuhanna et al. // Circulation. 2002. — Vol. 106. — P. 1439−1441.
- Deng, L.Y. Effect of hypertension induced by nitric oxide synthase inhibition on structure and function of resistance arteries in the rat / L.Y. Deng // Clin. Exp. Hypertens. -1993. Vol. 15. — P. 527−537.
- Detection of Chlamydia pneumoniae (TWAR) in human coronary atherectomy tissue / L.A. Campbell, F.R. O’Brien, A.L. Cappuccio et al. // J. Infect. Dis. 1996. — Vol. 172. — P. 585−588.
- Detection of enterovirus, cytomegalovirus, and Chlamydia pneumoniae in atheromas / T.W. Kwon, D.K. Kim, J.S. Ye et al. // J. Microbiol. 2004. — Vol. 42, N 4. — P. 299−304.
- Detection of nanobacteria-like particles in human atherosclerotic plaques / L.G. Puskas, L. Tiszlavicz, Z. Razga et al. // Acta Biol. Hung. -2005. Vol. 56, N 3−4. — P. 233−245.
- Devasenapathy, N. Remote ischaemic preconditioning / N. Devasenapathy, G. Karthikeyan // Lancet. 2007. — Vol.370. — P. 9604
- Development of 'no-reflow' phenomenon in ischemia/reperfusion injury: failure of active vasomotility and not simply passive vasoconstriction / J. Nanobashvili, C. Neumayer, A. Fuegl et al. // Eur. Surg. Res. 2003. -Vol. 35, № 5.-P. 417−424.
- Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits—comparison with lovastatin / R.H. Boger, S.M. Bode-Boger, R.P. Brandes et al. // Circulation. 1997. — Vol. 96. — P. 1282−1290.
- Differential Aspects of Endothelial Function of the Coronary Microcirculation Considering Myocardial Virus Persistence,
- Endothelial Activation, and Myocardial Leukocyte Infiltrates / K.B. Vallbracht, P.L. Schwimmbeck, U. Kuhl et al. // Circulation. -2005. Vol. 111, № 14. — P. 1784 — 1791.
- Diminished NO release in chronic hypoxic human endothelial cells / L. Ostergaard, E. Stankevicius, M. R. Andersen et al. // Am. J. Physiol. Heart. Circ. Physiol. 2007. — Vol. 293, № 5. — P. 2894−2903.
- Domenico, R. Pharmacology of nitric oxide: molecular mechanisms and therapeutic strategies / R. Domenico // Curr. Pharm. Des. 2004. — Vol. 10, № 14.-P. 1667−1676.
- Downregulation of eNOS mRNA expression by TNF alpha: identification and functional characterization of RNA-protein interactions in the 3'UTR / P.F. Lai, F. Mohamed, J.C. Monge et al. // Cardiovasc. Res. 2003. — Vol. 59. — P. 160−168.
- Drew, B. Ageing and the role of reactive nitrogen species / B. Drew, C. Leeuwenburch // Ann. N. J. Acad. Sci. 2002. — Vol. 959, № 1. — P. 6681.
- Dunne, M. Infectious Agents and Cardiovascular Disease / M. Dunne // The Infectious Etiology of Chronic Diseases: Defining the Relationship, Enhancing the Research, and Mitigating the Effects Washington, D.C.: The National Academic Press, 2004.
- Dunne, M. WIZARD and the design of trials for secondary prevention of atherosclerosis with antibiotics / M. Dunne // Am. Heart J. 1999. -Vol. 138, № 5, Pt. 2. — P. 542−544.
- Eady, E. The use of antibiotics in acne therapy: oral or topical administration/ E. Eady, K. Holland, W. Cunliffe // J. Antimicrob. Chemother. 1982. — Vol. 10. — P. 89−115.
- Early induction of transforming growth factor-beta via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats / H. Tomita,
- K. Egashira, Y. Ohara et al. // Hypertension. 1998. — Vol. 32. -P. 273 -279.
- Effect of Azithromycin on Murine Arteriosclerosis Exacerbated by Chlamydia pneumoniae / N.M. Rothstein, T.C. Quinn, G. Madico et. al. // J. Infect. Dis. -2001. Vol. 183, № 2. — P. 232−238.
- Effect of clarithromycin and azithromycin on production of cytokines by human, monocytes/ A.A.Khan, T.R.Slifer, F.G. Araujo, J.S. Remington //Int J Antimicrob Agents. 1999. — Febl 1(2). — P. 121−32.
- Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections / J. Tamaoki, K. Takeyama, E. Tagaya et al. // Antimicrob. Ag. Chemother. 1995. — Vol. 39. -P. 1688−1690.
- Effect of dietary antioxidants on endothelial dysfunction induced by high-fat meel / K. Esposito, F. Nappo, G. Giugliano et al. // Am. J. Clin. Nutrition. 2003. — Vol. 77, № 1. — P. 139−143.
- Effect of eiythrormycin on Haemophilus influenza endotoxin-induced release of IL-6, IL-8 and ICAM-1 by cultured human bronchial epithelial cells / O. Khair, J. Devalia, M. Abdelaziz et al. // Europ. Respir. I. 1995. -Vol. 8.-P. 1451−1457.
- Effect of erythromycin on homocysteine-induced extracellular matrix metalloproteinase-2 production in cultured rat vascular smooth muscle cells Indian / H. Guo, J.D. Lee, H. Yue et al. // J Med Res. 2005. — Vol. 121. -P.764−770.
- Effect of erythromycin on matrix metalloproteinase-9 and cell migration / N. Hashimoto, T. Kawabe, T. Hara et al. // J Lab Clin Med. -2001.- Vol. 137. -P.176−183.
- Effect of L-arginine infusion on systemic and renal hemodynamics in hypertensive patients / Y. Higashi, T. Oshitna, R. Orono et al. // Am. J. Hypertens. 1999. — Vol. 12. — P. 8−12.
- Effect of macrolide antibiotics on human endothelial cells activated by Chlamydia pneumoniae infection and tumor necrosis factor-alpha / S.M. Uriarte, R.E. Molestina, R.D. Miller et al. // J. Infect. Dis. 2002. -Vol. 185.-P. 1631−1636.
- Effect of shear stress on asymmetric dimethylarginine release from vascular endothelial cells / T. Osanai, M. Saitoh, S. Sasaki et al. // Hypertension. 2003. — Vol. 42. — P. 985−990.
- Effect of Treatment on Flow Dependent Vasodilation of the Brachial Artery in Essential Hypertension / M.L. Muiesan, M. Salvetti, C. Monteduro et al. // Hypertension. 1999. — Vol. 33. — P. 575−580.
- Effects of azithromycin on fecal flora of healthy adult volunteers / U. Uchino et al. // Jpn. J. Antibiot. 1995. — Vol. 48, № 9. — P. 1119—1130.
- Effects of clarithromycin on inflammatory cell mediator release and survival / P.D.Borszcz, D. Befiis, R. Moqbel et al. // Chemotherapy. 2005. -Vol.51 (4).-P. 206−10.
- Effects of L-arginine on fibroblast growth factor 2-induced angiogenesis in a model of endothelial dysfunction / P. Voisine, J. Li, C. Bianchi et al. // Circulation. 2005. — Vol. 112. — P. 1202−1207.
- Effects of low-dose L-arginine on insulin-mediated vasodilatation and insulin sensitivity / T.C. Wascher, W.F. Grauier, P. Dittrich et al. // Eur. J. Clin. Invest. 1997. — Vol. 27. — P. 690—695.
- Effects of macrolide antibiotics on neurally mediated contraction of human bronchus / J. Tamaoki, E. Tagaya, A. Sakai, K. Konno // J. Allergy Clin. Immunol. 1995. — Vol. 95. — P.853−859.
- Effects of macrolides on interleukin-8 secretion from human nasal epithelial cells / K. Fujita, T. Shimizu, Y. Majima, Y. Sakakura // Eur. Arch. Otorhinolaryngol. 2000. — Vol. 257, № 4. — P. 199−204.
- Effects of roxithromycin and eiythromycin on interleukin 8-induced neutrophil recruitment and goblet cell secretion in guinea pig tracheas / J. Tamaoli, J. Nakata, E. Tagaya et al. // Antimicrob. Ag. Chemother. 1996. -Vol. 40.-P. 1726−1728.
- Effects of roxithromycin on proliferation of peripheral blood mononuclear cells and production of lipopolysaccharide-induced cytokines / T. Yoshimura, C. Kurita, K. Yamazaki et al. // Biol. Pharm. Bull. 1995. — Vol. 18. — P. 876−881.
- Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels / J. Zhu, A.A. Quyyumi, J.E. Norman et al. // Am. J. Cardiol. 2000. — Vol. 85, N 2. — P. 140−146.
- Eiythromycin inhibition of lipopolysaccharide-stimulated tumour necrosis factor alpha production by human monocytes in vitro / Y. Lino, M. Toriyama, K. Kudo et al // Ann. Otology, Rhin. Laryngol. 1992. -Suppl. 157.-P. 16−20.
- Eiythromycin promotes monocyte to macrophage differentiation / N. Keicho, S. Kudoh, H. Yotsumoto, K. Akagawa // J. Antibiotics. 1994. -Vol. 47. — P.80−89.
- Eiythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients / Y. Ichikawa, H. Ninomiya, H. Koga et al / /Am. Rev. Respir. Dis. 1992. -Vol. 146.-P. 196−203.
- Eiythromycin reduces the severity of bronchial hyperresponsiveness in asthma / H. Miyatake, F. Taki, H. Taniguchi et al. // Chest. 1991.1 Vol. 99. -P.670−673.
- Eiythromycin suppresses interleukin-6 expression by human bronchial epithelial cells: a potential mechanism of its anti-inflammatory action / H. Takizawa, M. Desaki, T. Ohtoshi et al. // Biochem. Biophys. Res. Com. -1995.-Vol.210.-P.781−786.
- Ekici, A. Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma / A. Ekici, M. Ekici // J. Asthma. 2002. — Vol. 39, № 2. — P. 181−185.
- Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction / S. Gupta, E.W. Leatham, D. Carrington et al. // Circulation. 1997. — Vol. 96. -P. 404−407.
- Elevation of tumor necrosis factor and increased risk of recurrent coronary events after myocardial infarction / P. Ridker, N. Rifai, M. Pfeffer et al. // Circulation. 2000. — Vol. 101. — P. 2149.
- Endemann, D.H. Endothelial Dysfunction / D.H. Endemann, E.L. Schiffrin // J. Am. Soc. Nephrol. 2004. — Vol. 15. — P. 19 831 992.
- Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis / H. Miyazaki, H. Matsuoka, J.P. Cooke et al. // Circulation. -1999.-Vol. 99.-P. 1141−1146.
- Endothelial actin cytoskeleton remodeling during mechanostimulation with fluid shear stress / E.A. Osborn, A. Rabodzey, C.F. Dewey Jr., J.H. Hartwig // Am. J. Physiol. Cell. Physiol. 2006. — Vol. 290, № 2. — P. C444-C4552.
- Endothelial dysfunction and circadian blood pressure rhythmicity in young heart transplant recipients / D.A. Parra, D.S. Lim, C.L. Buller, J.R. Charpie // Pediatr. Cardiol. 2007. — Vol. 28, № 1. — P. 1−7.
- Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide / G. Hasdan, S. Benchetrit, G. Rashid et al. //Kidney. Int. 2002. — Vol. 61. — P. 586−590.
- Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition / M. Clozel, H. Kuhn, F. Hefti et al. // Hypertension. 1991. — Vol. 18. -P.132−141.
- Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease / T. Heitzer, T. Schlinzig, IC. Krohn et al. // Circulation. 2001. — Vol. 104. — P. 2673−2678.
- Endothelial dysfunction: a comprehensive appraisal / R.J. Esper, R.A. Nordaby, J.O. Vilarino et al. // Cardiovasc. Diabetol. 2006. — Vol. 23.- P. 47−57.
- Endothelin-1 induces NAD (P) H oxidase in human endothelial cells / N. Duerrschmidt, N. Wippich, W. Goettsch et al. // Biochem. Biophys. Res. Comm. 2000. — Vol. 269. — P. 713−717.
- Endothelium, aging, and hypertension / S. Taddei, A. Virdis, L. Ghiadoni et. al. // Curr. Hypertens. Rep. 2006. — Vol. 8, № 1. — P. 84−89.
- Enhanced interleukin production after long-term administration of eiythomycin stearate/E. Kita, M. Sawaki, F. Nishikawa et al. // Pharmacology. 1990. — Vol. 47. — P. 177−183.
- Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency / N.D. Vaziri, Z. Ni, F. Oveisi et al. // Hypertension. 2002. — Vol. 39. — P. 135−141.
- Epstein Insights Into the Role of Infection in Atherogenesis and in Plaque Rupture // Circulation. 2009. — Vol. 119. — P. 3133−3141.
- Epstein, S.E. Infection and Atherosclerosis: Emerging Mechanistic Paradigms / S.E.Epstein, Y.F. Zhou, J. Zhu // Circulation. 1999. -Vol. 100, N4.-P. 20−28.
- Ernst, E. Fibrinogen and cardiovascular risk / E. Ernst, W. Koenig 11 Vascular Med. 1997. — Vol. 2. — P. 115−125.
- Erythromycin and clarithromycin attenuate cytokine-induced endothelin-1 expression in human bronchial epithelial cells / H. Takizawa, M. Desaki, T. Ohtoshi et al. // Eur Respir J. 1998. — Vol. 12 -P. 57−63.
- Erythromycin suppresses nuclear factor-kappa B and activator protein-1 activation in human bronchial epithelial cells / M. Desaki, H. Takizawa, T. Ohtoshi et al. // Biochemical and Biophysical Research Communications. 2000. -Vol. 267.-P. 124−128.
- Erythromycin-induced suppression of pulmonary antibacterial defenses/ S. Nelson, W. Summer, P. Terry et al. // Am. Rev. Respir. Dis. -1987.-Vol. 136.-P.1207−1212.
- Esterly, N. The effect of antimicrobial agents on leukocyte Chemotaxis / N. Esterly, N. Furey, L. Flanagan // J. Invest. Dermatol. 1978. — Vol. 70. — P.51−55.
- Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves / V.M. Miller, G. Rodgers, J.A. Charlesworth et al. // Am. J. Physiol. Heart Circ. Physiol. 2004. — Vol. 287, N 3. — P. Hl 115−1124.
- Expression of adgesion molecules on endothelial cells stimulated by Chlamydia pneumoniae /S.S. Kaukoranta-Tolvanen, T. Ronni, M. Leinonen et al. // Microb. Pathog. 1996. — Vol. 21. — P. 407−411.
- Fan, J. Transcriptional mechanisms of acute lung injuiy / J. Fan, R.D. Ye, A.B. Malik // Am. J. Physiol. Lung. Cell. Mol. Physiol. 2001. — Vol. 281. -P.L1037-L1050.
- Fayad, V. Fuster Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque / V. Fayad // Circulation. Research. -2001. Vol. 89. — P. 305.
- Feletou, M. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture) / M. Feletou, P.M. Vanhoutte // Am. J. Physiol.
- Heart. Circ. Physiol. 2006. — Vol. 291, № 3. — P. H985−1002. Epub 2006 Apr 21.
- Femandes, P. The macrolide revival: 35 years after eiythromycin. / P. Femandes // Antimicrobic Newsletter. 1987. — Vol. 4. — P. 25−34.
- Ferdinandy, P. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning / P. Ferdinandy, R. Schulz // Br. J. Pharmacol. 2003. — Vol. 138, № 4. -P. 532−543.
- Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris / I. Juhan-Vague, S.D.M. Pyke, M.C. Alessi et al. // Circulation. 1996. — Vol. 94. — P. 2057−2063.
- Folsom, A. Antibiotics for prevention of myocardial infarction? Not yet! / A. Folsom // JAMA. 1999. — Vol. 281. — P. 461−462.
- Fong, I.W. Infections and their role in atherosclerotic vascular disease /I.W. Fong//J. Am. Dent. Assoc. 2002. — Vol. 133, Suppl. l.-P. 7−13.
- Fong, I.W. Sumamed in the treatment of the heart / I.W. Fong, // Clin. Diagn. Laboratory immunol. -1999.- № 6. P.891−894.
- Forstermann, U.T. Munzel Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace / U.T. Forstermann // Circulation.-2006.-Vol. 113(13).-P. 1708−1714.
- Gabriel, A.S. The prevalence of chronic Chlamydia pneumoniae infection as detected by polymerase chain reaction in pharyngeal samples from patients with ischaemic heart disease /A.S. Gabriel // Europ. Heart J. -1998. Vol. 19.-P. 1321−1327.
- Gabrielli, M. Azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome / M. Gabrielli, M. Candelli, L. Santarelli // Am. H. J. -2005. Vol. 150, Issue 1. — P. 9.
- Ganz, P. Testing endothelial vasomotor function: nitric oxide, a multipotent molecule / P. Ganz, J.A. Vita // Circulation. 2003. — Vol. 108, № 17.-P. 2049−2053.
- Gao, X. Inhibition of sulfur mustard-induced cytotoxicity and inflammation by the macrolide antibiotic roxithromycin in human respiratory epithelial cells / X. Gao, R. Ray, Y. Xiao // BMC Cell Biol. -2007.-Vol. 24, № 8.-P. 17.
- Girard, A.E. Correlation of increased azithromycin concentrations with phagocyte infiltration into sites of localized infection / A.E. Girard, C.R. Cimochowski, J.A. Faiella // J. Antimicrob. Chemother. 1996. -Vol. 37.-P. 9−19.
- Glader, C.A. Chlamydia pneumoniae Antibodies and High Lipoprotein (a) Levels Do Not Predict Ischemic Cerebral Infarctions: Results From a Nested Case-Control Study in Northern Sweden / C.A. Glader // Stroke. 1999. — Vol. 30, № 10. — P. 2013−2018.
- Glembotski, C.C. Endoplasmic Reticulum Stress in the Heart /
- C.C. Glembotski // Circ. Res. 2007. — Vol. 101, № 10. — P. 975−984.
- Glucocorticoidls regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport / W.W. Simmons,
- D. Ungureanu-Longrois, G. K. Smith et al. // J. Biol. Chem. 1996. -Vol. 271.-P. 23 928−23 937.
- Glucocorticoids mediate the enhanced expression of intestinal type II arginase and argininosuccinate lyase in postweaning pigs / N.E. Flynn, C.J. Meininger, K. Kelly et al. // J. Nutr. 1999. — Vol. 129. — P. 799−803.
- Goldstein, L.B. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke
- Gordon, E.M. Rationale for single and high dose treatment regimens with azithromycin / E.M. Gordon, J.L. Blumer // Pediatr. Infect. Dis. J. — 2004. — Vol. 23, № 2. — P. 102—107.
- Goswami, S. Eiythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro / S. Goswami, S. Kivity, Z. Marom // Am. Rev. Respir. Dis. 1990. — Vol. 141. — P.72−78.
- Gratton, M.T. CMV infection is associated with cardiac allograft rejection and atherosclerosis / M.T. Gratton // JAMA. 1989. — Vol. 26. -P. 3561−3566.
- Grayston, J.T. Chlamydia pneumoniae (TWAR) and coronary heart disease: from hypothesis to treatment / J.T. Grayston // Abstracts of Proceedings of the IV Meeting of the European Society for Chlamydial Research. P. 380−381.
- Grayston, J.T. Chlamydia pneumoniae, strain TWAR pneumoniae / J.T. Grayston // Annu. Rev. Med. 1992. — Vol. 43. — P. 317−323.
- Grayston, J.T. Epidemiology of Chlamydia pneumonia (TWAR) / J.T. Grayston // Abstracts of Proceedings of the 3rd Meeting of the European Society for Chlamydial Research. P. 2111−212.
- Grayston, J.T. Infections caused by Chlamydia pneumoniae strain TWAR / J.T. Grayston // Clin. Infect. Dis. 1992. — Vol. 15. — P. 757−763.
- Green, D.R. Gone but not forgotten / D.R. Green, H.M. Beere // Nature. -2000.-Vol. 405.-P. 28−29.
- Griendling, K.K. Oxidative stress and cardiovascular disease / K.K. Griendling, R.W. Alexander // Circulation. 1997. — Vol. 96. — P. 3264−3265.
- Griendling, K.K. Oxidative stress and cardiovascular injury: Part I: Basic mechanisms and in vivo monitoring of ROS / K.K. Griendling, G.A. FitzGerald // Circulation. 2003. — Vol. 108. — P. 1912−1916.
- Griffits, P.W. Nitric oxide synthases: properties and catalytic mechanism / P.W. Griffits, D. J. Stuehr // Ann. Rev. Physiol. 1995. — Vol. 57. — P. 707—736.
- Guoyao, W.U., Arginine metabolism: nitric oxide and beyond / W.U. Guoyao, S. M. Morris // Biochem. J. 1998. — Vol. 336. — P. 1−17.
- Gupta, S. Azithromycin and myocardial infarction / S. Gupta, E.W. Leatham // Circulation. 1998. — Vol. 96, № 1. — P. 454−467.
- Gupta, S. Azithromycin and Rulid in post-myocardial infarction patients with elevated Chlamydia pneumoniae antibody titres / S. Gupta // J. Am Coll. Cardiol. 1998.-Vol. 17.-P.200−211.
- Gupta, S. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction / S. Gupta, E. W Leatham // Circulation. 1997. — Vol. 96, № 2. — P. 404−407.
- Gurfinkel, E. Inflammation, infection, or both in atherosclerosis: the ROXIS trial in perspective / E. Gurfinkel // J. Infect. Dis.- 2000. Vol. 181, (suppl3j. — P. S566-S568.
- Gurfinkel, E.P. Emerging role of antibiotics in atherosclerosis / E.P. Gurfinkel, G. Bozovich // Am. Heart J. 1999. — Vol. 138, № 5, Pt. 2. -P. 537−538.
- Guven, M. Bacterial etiology of acute otitis media and clinical efficacy of amoxicillin-clavulanate versus azithromycin / M. Guven // Int. J. Pediatr. Otorhinolaryngol. — 2006. — Vol. 70, № 5. P. 915 923.
- Hajjar,. D.F. Viral pathogenesis of atherosclerosis / D.F. Hajjar // J. Pathol. 1991.-Vol. 139.-P. 1993−1211.
- Hamada, K. Antitumor effect of erythromycin in mice / K. Hamada // Chemotherapy. 1995. — Vol. 41. — P. 59−69.
- Hammerschlag, M.R. Advances in the management of Chlamydia pneumoniae infections / M.R. Hammerschlag // Expert. Rev. Anti Infect. Ther. 2003. — Vol. 1, N 3. — P. 493−503.
- Hammerschlag, M.R. The intracellular life of chlamydiae / M.R. Hammerschlag // Semin. Pediatr. Infect. Dis. 2002. — Vol. 13, N 4. -P. 239−248.
- Hamson, D.G. Endothelial function and oxidant stress / D.G. Hamson // Clin. Cardiol. 1997. — Vol. 20 (Sil). — P. II-11−11−17.
- Hand, W. Antibiotic inhibition of the respiratory Durst response in human polymorphonuclear leukocytes / W. Hand, D. Dand, N. King-Thompson // Antimicrob. Ag. Chemother. 1990. — Vol. 34. -P. 863−870.
- Hand, W.L. Increased poly-morphonuclear leukocyte respiratory burst function in type 2 diabetes / W.L. Hand, D.L. Hand, Y. Vasquez // Diabet Res Clin Pract, 2006, — Sep 5.
- Hankey, G.J. Potential New Risk Factors for Ischemic Stroke: What Is Their Potential? / G.J. Hankey // Stroke. 2006. — Vol. 37. — P. 2181−2188.
- Harrison, D.C. Cellular and molecular mechanisms of endothelial cell dysfunction / D.C. Harrison // J. Clin. Invest. — 1997. — Vol. 100. — P. 2153—2157.
- Harrison, D.G. Cellular and molecular mechanisms of endothelial cell dysfunction / D.G. Harrison // J. Clin. Invest. 1997. — Vol. 2. — P. 21 532 157.
- Hellewell, P. Immunopharmacology of neutrophils / P. Hellewell, P. Williams London: Acad. Press, 1994.
- Helmersson, J. Prostaglandin F (2alpha) metabolite and F2-isoprostane excretion in migraine / J. Helmersson, P. Mattsson, S. Basu // Clin. Sei. 2002. — Vol. 102. — P. 39−43.
- Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris / S.G. Thompson, J. Kienast, S.D.M. Pyke et al. //N. Engl. J. Med. 1995. — Vol. 332. — P. 635−641.
- Hepatic steatosis is associated with an increased risk of carotid atherosclerosis / H. Volzke, D.M. Robinson, V. Kleine et al. // World J. Gastroenterol.-2005.-Vol. 11, N 12.-P. 1848−1853.
- Hepatitis A IgG seropositivity and coronary atherosclerosis assessed by angiography / J. Auer, M. Leitinger, R. Berent et al. // Int. J. Cardiol. -2003. Vol. 90, N 2−3. — P. 175−179.
- Hepatitis B and C virus infection and the risk of atherosclerosis in a general population / H. Volzke, C. Schwahn, B. Wolff et al. // Atherosclerosis. 2004. — Vol. 174, N 1. — P. 99−103.
- Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese / K.C. Yang, M.F. Chen, T.C. Su et al. // Atherosclerosis. 2006. — electronic publication ahead of print.
- Hepatitis C virus and atherosclerosis in patients with type 2 diabetes / M. Fukui, Y. Kitagawa, N. Nakamura, T. Yoshikawa // JAMA. 2003. -Vol. 289, N 10. — P. 1245−1246.
- Herpesvirus DNA (Epstein-Barr virus, herpes simplex virus, cytomegalovirus) in circulating monocytes of patients with coronary artery disease / A. Schlitt, S. Blankenberg, K. Weise et al. // Acta Cardiol. 2005. -Vol. 60, N6.-P. 605−610.
- Higgins, J.P. Chlamydia pneumoniae and coronary artery disease: the antibiotics trials / J.P. Higgins // May. Clin. Proc. 2003. — Vol. 78. — P. 321 332.
- High levels of CMV antibody in patients requiring vascular surgery for atherosclerosis / E. Adam, J.L. Melnick, B.L. Pelrie et al. // Lancet. -1987.-Vol. 2.-P. 291−293.
- High-glucose-altered endothelial cell function involves both disruption of cell-to-cell connection and enhancement of force development / K. Nobe, M. Miyatake, T. Sone, K.J. Honda // Pharmacol. Exp. Ther. -2006. Vol. 318, № 2. — P. 530−539. Epub 2006.
- Homma, H. Definition of diffuse panbronchiolitis / H. Homma // Jap. Int. Med. 1976. — Vol. 65. — P. 649−659.
- Hori, S. Macrolides increase endogenous glucocrticoid levels. In: The 36th Conference on Antimicrobial Agents and Chemotherapy / S. Hori, J. Sato, M. Kawamura. New Orleans, 1996, — abstr. P.83.
- Hornstein, C. Stress, anxiety and cardiovascular disease: an interdisciplinary approach / C. Hornstein // Vertex. 2004. — Vol. 15. — P. 2131.
- Huang, Y. Ischemia-reperfusion and immediate T cell responses / Y. Huang, H. Rabb, K.L. Womer // Cell. Immunol. 2007. — Vol. 248, № 1. — P. 4−11. Epub 2007 Oct 17. Review.
- Ialenti, A. Role of nuclear factor-kappaB in a rat model of vascular injury Naunyn Schmiedebergs / A. Ialenti, A. Ianaro, P. Maffia // Arch. Pharmacol. 2001. — Vol. 364, № 4. — P. 343−350.
- Ianaro, A. Anti-inflammatory activity of macrolide antibiotics / A. Ianaro, A. Ialenti, P. Maffia // J. Pharmacol. Exp. Ther. 2000. — Vol. 292, № l.-P. 156−163.
- Identification of nitric oxide synthase as a protective locus against tuberculosis / J.D. MacMicking, R.J. North, R. LaCourse et al. // Proc. Natl. Acad. Sei. USA. 1997. — Vol. 94. — P. 5243−5248.
- Identification of protein disulfide isomerase as an endothelial hypoxic stress protein / K.K. Graven, C. Molvar, J.S. Roncarati et al. // Am. J. Physiol. Lung. Cell. Mol. Physiol. 2002. — Vol. 282, № 5. -P. 996−1003.
- IgG subclass-specific antibodies in Chlamydia pneumoniae infections / T. Anttila, M. Leinonen, H.M. Surcel et al. // Scand. J. Infect. Dis. 1998. -Vol. 30, № 4.-P. 381−386.
- Ignarro, L.J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview / L.J. Ignarro, C. Napoli, J. Loscalzp // Circulat. Res. 2002. — Vol. 90, № 1. — P. 21—28.
- Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin 1 production of murine peritoneal macrophages / K. Takeshita, I. Yamagishi, M. Harada et al. // Drugs Exp. Clin. Res. -1989. Vol.15.-P.527−533.
- Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro / K. Morikawa, F. Oseko, S. Morikawa, K. Iwamoto // Antimicrob Agents Chemother. 1994. — Nov 38(11). — P.2643−2647.
- Immunopathogenesis of Atherosclerosis * Response / J.W. Auer, R. Berent, T. Weber et al. // Circulation. 2002. — Vol. 105, N 10. — P. 64.
- Impact of Infectious Burden on Extent and Long-Term Prognosis of Atherosclerosis / C. Espinola-Klein, H.J. Rupprecht, S. Blankenberg et al. // Circulation. 2002. — Vol. 105, N 1. — P. 15−21.
- In vitro and ex vivo effects of recent and new macrolide antibiotics onchemotaxis of human polymorphonuclear leukocytes / D. Torre, M. Broggini, V. Botta et al. // J. Chemother. 1991. — Vol. 3. — P.236−239.
- In vitro susceptibility of human vascular wall cells to infection with Chlamy-dia pneumoniae / K. Godzik, E. O’Brien, S.K. Wang, C.C. Kuo // J. Clin. Microb. 1995. — Vol. 33. — P. 2411−2414.
- In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells / T. Shimuzu, S. Shimuzu, R. Hattori et al. // Am. J. Respir. Crit. Care. Med.-2003.-Vol. 168.-P. 581−587.
- Ince, C. The microcirculation is the motor of sepsis / C. Ince // Critical Care. 2005. — Vol. 9, N. 4. — P. s.13 — s.19.
- Inducible nitric-oxide synthase generates superoxide from the reductase domain / Y. Xia, L.J. Roman, B.S.S. Masters, J.L. Zweier // J. Biol. Chem. -1998. Vol. 273. — P. 22 635−22 639.
- Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model / J.B. Muhlestein, J.L. Anderson, E.H. Hammond et al. // Circulation. -1998. Vol. 97, N 7. — P. 633−636.
- Infection with chlamydia pneumoniae accelerates the induction and progression of atherosclerosis in diet induced hypercholesteremic C 57
- BL/6S mice / E. Blessing, L.A. Campbell, M. Rosenfeld, C.C. Kuo // J. Infect. Dis. 2002. — Vol. 186, № 2. — P. 247.
- Inflammatory and hemodynamic changes in the cerebral microcirculation of aged rats after global cerebral ischemia and reperfiision / L. Ritter, J. Funk, L. Schenkel et al. // Microcirculation. 2008. — Vol. 15, № 4.-P. 297−310.
- Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing alpha-5 beta-1 integrin expression and function / G. Barillari, L. Albonici, S. Incerpi et al. // Atherosclerosis. -2001.-Vol. 154.-P. 377.
- Infliximab Improves Endothelial Dysfunction in Systemic Vasculitis: A Model of Vascular Inflammation / A.D. Booth, D.R.W. Jayne, R.K. Kharbanda et al. // Circulation. -2004. -Vol. 109, № 14. P. 1718−1723.
- Influence of peroxynitrite on energy metabolism and cardiac function in a rat ischemia-reperfusion model / W.H. Lee, J.S. Gounarides, E.S. Roos, M.S. Wolin // Am. J. Physiol. Heart. Circ. Physiol. 2003. — Vol. 285, № 4. -P. 1385−1395.
- Influence of roxithromycin on cell-mediated immune responses / S. Konno, M. Adachi, K. Asano et al. //Life Sciences. 1992. — Vol. 51. -P.107−112.
- Influenza and cardiovascular disease: is there a causal relationship? / M. Madjid, I. Aboshady, I. Awan et al. // Tex. Heart Inst. J. 2004. — Vol. 31, N 1. -P. 4−13.
- Influenza Virus Infection, Infectious Burden, and Atherosclerosis / J. Auer, R. Berent, T. Weber, B. Eber // Stroke. 2002. — Vol. 33, N 6. -P. 1454−1455.
- Inhibition by erythromycin of superoxide anion production by human polymorphonuclear leukocyte through the action of cyclic AMP-dependent protein kinase / T. Mitsuyama, T. Tanaka, K. Hidaka et al. // Respiration. -1995.-Vol. 62.-P. 269−273.
- Inhibition of NO synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels / H. Tomita, K. Egashira, M. Kubo-Inoue et al. // Arterioscle. Thromb. Vase. Biol. 1998. — Vol. 18. — P. 1456 — 1464.
- Inhibitory effect of eiythromycin on interleukin 8 production by 1 alpha, 25-dihydroxyvitaminD3-stimualted THP-1 cells / T. Fujii, J. Kadota, T. Morikawa et al // Antimcirob. Ag. Chemother. 1996. — Vol. 40. -P. 1548−1551.
- Interaction de la roxithromycin avec le polynucleare neutrophile humain in-vitro et ex vivo / M. Labro, A. Bryskier, C. Babin-Chevaye, J. Hakim //Pathologie Biol. 1988. — Vol. 36. — P. 711−714.
- Interleukin-6 gene transcripts are expressed in human atherosclerotic lesions / Y. Seino, U. Ikeda, M. Ikeda et al. // Cytokine. 1994. — Vol. 6. -P. 87−91.
- Interleukin-6 stimulates coagulation, not fibrinolysis, in humans / J.M.L. Stouthard, M. Levi, C.E. Hack et al. // Thromb. Haemost. 1996. -Vol. 76.-P. 738−742.
- Inverse association of Chlamydia pneumoniae infection with high blood pressure in Japanese adults / M. Nishimura, M. Ushiyama, A. Nanbu et al. // Am. J. Hypertens. 2001. — Vol. 14, № 1. — P. 20−26.
- Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration / G. Cao, C. D. O’Brien, Z. Zhou et al. // Am. J. Physiol. Cell. Physiol. 2002. — Vol. 282, № 5. — P. 1181 — 1190.
- Itkin, I. The use of macrolide antibiotic substances in the treatment of asthma /1. Itkin, M. Menzel //J. Allergy. 1970. — Vol. 45. — P. 146−162.
- Jacobs, R.F. Pharmacokinetics of intravenously administered azithromycin in pediatric patients / R.F. Jacobs // Pediatr. Infect. Dis. J. 2005. — Vol. 24, № 1. — P. 34−39.
- Jespersen, C.M. Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial / C.M. Jespersen, B. Als-Nielsen // BMJ. 2006. -Vol. 332.-P. 22−27.
- John, P. Chlamydia pneumoniae and Coronary Artery Disease: The Antibiotic Trials / P. John, M.D. Higgins, M. Phil // Mayo Clinic Proc. -2003.-Vol. 78.-P. 323−32.
- Jordan, J.E. The role of neutrophils in myocardial ischemia-reperfusion injury / J.E. Jordan, Z.Q. Zhao, J. Vinten-Johansen // Cardiovasc. Res. 1999. — Vol. 43. — P. 860−878.
- Kadota, J. Non-antibiotic effect of antibiotics / J. Kadota // Clin. Microbiol. Inf. 1996. — № 1 (suppl. 2). — P.20−22.
- Kajander, E.O. Nanobacteria-propagating calcifying nanoparticles / E.O. Kajander // Lett. Appl. Microbiol. 2006. — Vol. 42, N 6. — P. 549−552.
- Kalayoglu, M.V. Induction of macrophage foam cell formation by Chlamydia pneumoniae / M.V. Kalayoglu, G.I. Byrne // J. Infect. Dis. -1998.-Vol. 177.-P. 725−729.
- Kanai, Ken-Ichi. Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro / Ken-ichi Kanai // Research Communication. Mediators of Inflammation. 2005. — January 1.
- Kardas, P. A blinded comparison of payability of 13 common pediatric antibiotic suspensions / P. Kardas, M. Muras // Wiad. Lek. -2005. Vol. 58, №. 1−2. — P. 15−20.
- Karpov, O. Single oral 1,5 g azithromycin dose in the treatment of uncomplicated tonsillitis in adults — a pilot study / O. Karpov, A. Zaytsev, S. Karpischenko // 5-th Intern. Conf. of ICMAS. — Seville, 2000. — № 4.13. — P. 38.
- Kauser, K. Role of endogenous nitric oxide production of atherosclerosis in apolipoprotein E-deficient mice / K. Kauser, V. Cunha, R. Fitch // Am. J. Physiol. Heart. Circulat. Physiol. 2003. — Vol. 278. -P. H1679-H1685.
- Keaney, J.F. Jr. The value of inflammation for predicting unstable angina / J.F. Keaney Jr., J.A. Vita // N. Engl. J. Med. 2002. — Vol. 347. -P. 55−57.
- Kirst, H. New macrolides: expanded horizons for an old class of. antibiotics / H. Kirst / /J. Antimicrobial Chemotherapy. 1991. — Vol. 28. -P. 787−790.
- Klochkov, V.A. Effect of therapy with antibiotics on lipid metabolism and antioxidant reserve of patients with ischemic heart disease during
- Chlamydia pneumoniae infection / V.A. Klochkov, Pla. Dovgalevskii, K.S. Umetskii // Kardiologiia. 2005. — Vol. 45, № 12. — P. 58−61.
- Kobayashi, H. Biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides/ H. Kobayashi // Am. J. Med. -995. -Vol. 99 (suppl. 6A). P. 26−30.
- Kobayashi, H. Airway biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides / H. Kobayashi // J. Inf. Chemotherapy. 1995. — Vol. 1. — P. 1−15.
- Kobayashi, H. Biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides / H. Kobayashi // Am. J. Med. 1995. — Vol. 99 (suppl. 6A). — P 26−30.
- Konno, S. Anti-allergic activity of roxithromycin: inhibition of interleukin-5 production from mouse T lymphocytes / S. Konno // Life Sciences. 1993. — Vol. 52. — P. 25−30.
- Kuo, C.C. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15−35 years) / C.C. Kuo // Proc. Natl. Acad. Sci. USA. 1995. -Vol. 92.-P. 6911−6914.
- Kuppuswamy, V.C. Antibiotic therapy for coronary heart disease: the myth and the reality / V.C. Kuppuswamy, S. Gupta // Timely Top. Med. Cardiovasc. Dis. 2006. — Vol. 10. — P. E2.
- Kuvin, J.T. Effect of short-term antibiotic treatment on Chlamydia pneumoniae and peripheral endothelial function /
- J.T. Kuvin, N. Gokce, M. Holbrook // American Journal of Cardiology. 2003. — Vol. 15. — P. 732−735.
- Labor, M. Investigation of the mechanism undelying the stimulation of neutrophil exocytosis by macrolides. 35th Interscience Conf. on Antimicrob / M. Labor, H. Abdelghaffar, A. Bryskier // Ag. Chemother. San Francisco. 1995. — P. 165.
- Labro, M. Comparison of various macrolides for stimulation of human neutrophil degranulation in vitro, / M. Labro // J. Antimicrob. Chemother. -1996.-Vol.38.-P. 81−93.
- Labro, M. Effects of roxithromycin and eiythromycin on human neutrophil functions ex-vivo. 1st Int. Conf. on the Macrolides, Azalides and Streptogramins / M. Labro, J. El Benna, J. Barre Lisbon. 1992. — P. 175.
- Labro, M. Interactions between antimicrobial drugs and phagocytes: an overview/ M. Labro // Int. J. Antimicrob. Agents. 1993. — Vol. 3. -P.73−87.
- Labro, M. Effects of macrolides on host natural defenses / M. Labro// Macrolides: Chemistry, Pharmacology and Clinical Uses /eds. A. Bryskier et al. Paris: Amette-Blackwell. — 1993. — P. 389−408.
- Labro, M. Immnunomodulation by antibacterial agents. Is it clinically relevant / M. Labro // Drugs. 1993. — Vol. 45. — P. 319−328.
- Labro, M. Comparison of the in-vitro effects of several macrolides on the oxidative burst of human neutrophils / M. Labro, J. Benna, C. Babin-Chevaye // J. Antimicrob. Chemother. 1989. -Vol. 24.-P. 561−572.
- Labro, M. Interaction of macrolides with human neutrophils in vitro / M. Labro, H. Abdelghaffar, E. Mtaira // New Macrolides, Azalides and Streptogramins in Clinical Practice / H. Neu et al. -Marcel-Dekker. New York. 1995. P. 306−314.
- Labro, M.T. Anti-inflammatory activity of macrolides: a new therapeutic potential? / M.T. Labro // J. Antimicrob. Chemother. 1998. -Vol. 41. (suppl B). — P. 37−46.
- Labro, M.T. Interference of antibacterial agents with phagocytic functions: immunomodulation or «immuno-fairy tales» / M.T. Labro // Clin. Microbiol. Rev. 2000. — Vol. 13. — P. 615−660.
- Labro, M.T. Modulation of human polymorphonuclear neutrophil function by macrolides: preliminary data concerning dirithromycin / M.T. Labro, J. E1 Benna, H. Abdelghaffar // J. Antimicrob. Chemother. 1993. — Vol. 31. (suppl. C). — P. 51−64.
- Labro. M. Intraphagocytic penetration of macrolide antibiotics / M. Labro // Macrolides: Chemistry, Pharmacology and Clinical Uses / eds. A. Bryskier et al. Paris: Amette-Blackwell. — 1993. — P. 379−388.
- Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis / K.A. Coles, A.J. Plant, T.V. Riley et al. // Am. J. Cardiol. 1999. — Vol. 84, № 7. — P. 825−828.
- Laitinen, K. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits / K. Laitinen // Infect. Immun. 1997. — Vol. 65. № 11.- P. 4832−4835.
- Lam, C.F. Genetic modification of vascular endothelial function as therapeutic strategy in heart failure / C.F. Lam, Z.S. Katusic // Am. J. Physiol. Heart. Circ. Physiol. 2005. — Vol. 289, №> 2. — P. 518 — 519.
- Landmesser, U. Endothelial function: a critical determinant in atherosclerosis? / U. Landmesser, B. Hornig, H. Drexler // Circulation. 2004. — Vol. 109. — P. 1127−33.
- Lasky, L. Selectin-carbohydrate interactions and the initiation of the inflammatory response / L. Lasky // Ann. Rev. Biochem. 1995. — Vol. 64. -P. 113−139.
- Lassegue, B. R. E. Clempus Vascular NAD (P) H oxidases: specific features, expression, and regulation / B.R.E. Lassegue // Am. J. Physiol. Regulatory. Integrative. Comp. Physiol. -2003. Vol. 285, № 2. -P. R277 — R297.
- Laursen, J.B. Anti-inflammatory activity of macrolide antibiotics / J.B. Laursen // Circulation. 1997. — Vol. 95. — P. 588−593.
- Le Normand, Y. An example of simulation for a better understanding of PK/PD relationship of antibiotics / Y. le Normand, C Ganiere-Monteil, H. Drugeon // Pathol. Biol. 2004. — Vol. 52, № 10. — P. 597—601.
- Leclercq, B. Nitric oxide synthase and hypertension / B. Leclercq, E.A. Jaimes, L. Raij // Curr. Opin. Nephrol. Hypertens. 2002. — Vol. 11. -P. 185−189.
- Leinonen, M. Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis / M. Leinonen, P. Saikku // Am. Heart J. 1999. — Vol. 138, № 5, Pt. 2. — P. 504−506.
- Leucocyte response and anti-inflammatory cytokines in community acquired pneumonia / U.K. Kollinga, F. Hansena, J. Brauna et al. // Thorax. -2001.-Vol. 56.-P. 121−125.
- Levert, H. Azithromycin impact on neutrophil oxidativemetabolism depends on exposure time / H. Levert // Inflammation.-1998. Vol. 22, № 2. — P. 191−201.
- Liauder, L. Biology of nitric oxide signaling / L. Liauder, F.G. Soriano, C. Szabo // Crit. Care. Med. 2000. — Vol. 28. — P. 37−52.
- Liles, W. Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response /
- W. Liles, W. Van Voorkis // J. Infect Dis. 1995. — Vol. 172. -P.1573−1580.
- Lip, G.Y.H. Can we treat coronary artery disease with antibiotics? / G.Y.H. Lip, D.G. Beevers // Lancet. 1997. — Vol. 350. — P. 378−379.
- Long-term therapeutic effects of erythromycin and new quinolone antibacterial agents on diffuse panbronchiolitis / M. Yamamoto, A. Kondo, M. Tamura et al.//Jap. J. Thoracic Dis. 1990. — Vol. 28. — P. 1305−1313.
- Loscalzo, J. L Arginine in Atherosclerosis / J. Loscalzo // Arterioscler. Thromb. Vase. Biol. 2003. — Vol. 23, № 1. — P. 3−5.
- Lotter, K. In vivo efficacy of telithromycin on cytokine and nitric oxide formation in lipopolysaccharide-induced acute systemic inflammation in mice / K. Lotter, K. Hocherl, M. Bucher // J. Antimicrob. Chemother. -2006. Vol. 58, № 3. — P. 615−621.
- Lovmar, M. Kinetics of macrolide action: the josamycin and erythromycin cases / M. Lovmar, T. Tenson, M. Ehrenberg // J. Biol. Chem. 2004. — Vol. 279, № 51. — P. 53 506−53 515.
- Lucchesi, B.R. The role of the neutrophil and free radicals in ischemic myocardial injury / B.R. Lucchesi, S.W. Weras, J.C. Fantone // J. Mol. Cell. Cardiology. 1989.-Vol. 21.-P. 1241−1251.
- Luscher, T.F. Endothelial control of vascular tone and growth / T.F. Luscher // Clin. Exp. Hypertens. 1990. — № 12. — P. 897−902.
- Luscher, T.F. Endothelium derived vasoactive factors and regulation of vascular tone in human blood vessels / T.F. Luscher // Lung. — 1990. — Vol.168. -P. 27−34.
- Lusher, T.F. Vascular protection: current possibilities and future perspectives / T.F. Lusher // Clin. Pract. 2001. — Vol. 17. — P. 3−6.
- Lusis, AJ. Atherosclerosis/A.J. Lussis // Nature. 2000. — Vol. 407, № 6801.-P. 233−241.
- Macrolide antibiotics as anti-inflammatory agents: roxythromycin in an unexpected role / C. Agen, R. Danesi, C. Blandizzi et al. // Ag. Actions. 1993.-Vol. 30.-P. 85−90.
- Macrolide antibiotics inhibit nitric oxide generation by rat pulmonary alveolar macrophages / K. Kohri, J. Tamaoki, M. Kondo et al. // Eur. Respir. J. 2000. — Vol. 15, № 1. — P. 62−67.
- Macrolide antibiotics protect against endotoxin-induced vascular leakage and neutrophil accumulation in rat trachea / J. Tamaoki, N. Sakai, E. Tagaya et al. // Antimicrob. Ag. Chemother. 1994. — Vol. 38. -P.1641−1643.
- Macrolides and azalides attenuate the effects of bioactive phospholipids on human ciliated epithelium in vitro. 3rd Int. Conf. on the Macrolides / C. Feldman, A. Theron, G. Ramafi et al. //Azalides and Streptogramins. -Lisbon, 1996.-P.75.
- Macrolides inhibit epithelial cell-mediated neutrophil survival by modulating granulocyte macrophage colony-stimulating factor release / H. Yamasawa, K. Oshikawa, S. Ohno, Y. Sugiyama // Am. J. Respir. Cell. Mol. Biol. 2004. -Vol. 30, № 4.-P. 569−575.
- Magnitude and duration of the effect of sepsis on survival / A.A. Quartin, R.M. Schein, D.H. Kett, P.N. Peduzzi // JAMA. 1997. -Vol. 277.-P. 1058−1063.
- Mamod, N. Infarcts after surgery / N. Mamod, S. Cobbe, J.G. Pollock //BMJ.- 1995.-Vol. 310.-P. 1215−1216.
- Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease / B. Lindahl, H. Toss, A. Siegbahn et al. // N. Engl. J. Med. 2000. — Vol. 343. — P. 1139−1147.
- Martin, D. Alternative hypothesis for efficacy of macrolides in acute coronary syndromes / D. Martin // Lancet.- 1998. Vol. 351. -P. 1858−1859.
- Masahito, O. Clarithromycin Attenuates Acute and Chronic Rejection Via Matrix Metalloproteinase Suppression in Murine Cardiac Transplantation / O. Masahito // J Am Coll Cardiol. 2008. — Vol. 51. -P. 1977−1985.
- May, Michel J. Characterization of the IB-kinase NEMO Binding Domain / J. Michael May, B. Ralf Marienfeld, Sankar Ghosh // J. Biol. Chem. 2002. — Vol. 277, Issue 48. — P. 45 992−46 000.
- Mechanisms of disease: L-arginine in coronary atherosclerosis—a clinical perspective / D. Tousoulis, R.H. Boger, C. Antoniades et al. // Nat. Clin. Pract. Cardiovasc. Med. 2007. — Vol. 4, № 5. — P. 274−83.
- Meier, C.R. Acute respiratory tract infections and risk of first-time acute myocardial infarction / C.R. Meier, S.S. Jick, L.E. Derby // Lancet. -1998.— Vol. 351. P. 1467−1471.
- Meldrum, D.R. Tumor necrosis factor in the heart / D.R. Meldrum // Amer. J. Physiol. Regul. Integr. Comp. Physiol. 1998. — Vol. 274. -P. 577−595.
- Melhus, A. Expression of cytokine genes during pneumococcal and nontypeable H. influenzae acute otitis media in the rat / A. Melhus, A.F. Ryan // Infect. Immun. — 2000. — Vol. 68. -P. 4024−4031.
- Membrane stabilization in harvested vein graft storage: effects on adhesion molecule expression and nitric oxide synthesis / K.M. Vural, M.C. Oz, H. Liao et al. // Eur. J. Cardiothorac. Surg. 1999. — Vol. 16, № 2. -P. 150−155.
- Meniconi, A. Is arteriosclerosis an infectious disease? / A. Meniconi, G. Noll, T.F. Luscher // Schweiz. Rundsch. Med. Prax. 1998. — Vol. 87. -P. 64−74.
- Meurman, J.H. Oral health, atherosclerosis, and cardiovascular disease / J.H. Meurman, M. Sanz, S.J. Janket // Crit. Rev. Oral Biol. Med. ~ 2004. -Vol. 15, N6.-P. 403−413.
- Meyer, M. Azithromycin Reduces Exaggerated Cytokine Production by Ml Alveolar Macrophages in Cystic Fibrosis / M. Meyer // Am. J. Respir. Cell Mol. Biol.-2009.-P. 825−838.
- Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Thl cell responses / A. MacLean, X.Q. Wei, F.P. Huang et al. // J. Gen. Virol. 1998. — Vol. 79. — P. 825−830.
- Michel, T. Nitric oxide synthases: which, where, how and why / T. Michel, O. Feron // J. Clin. Invest. 1997. — Vol. 100. — P. 2146−2152.
- Microorganisms in the aetiology of atherosclerosis / S.A. Morre, W. Stooker, W.K. Lagrand et al. // J. Clin. Pathol. 2000. — Vol. 53, N 9. -P. 647−654.
- Mitochondrial arginase II modulates nitric-oxide synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells / G. Topal, A. Brunei, L. Walch et al. // J. Pharmacol. Exp. Ther. 2006. -Vol. 318, № 3.-P. 1368−1374.
- Miyazaki, H. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis / H. Miyazaki, H. Matsuoka, J.P. Cooke // Circulation. 1999. — Vol. 99. — P. 1141−1146.
- Modification of phagocitosis and cytokine production in peritoneal and splenic murine cells by azithromycin and josamycin / E. Ortega, M.A. Escobar, J.J. Gorio et al. // J. Antimicrob. Chemother. 2004. -Vol. 53.-P. 367−370.
- Modulatory effect of antibiotics on cytokine production by human monocytes in vitro / H. Watabe, K. Morikawa, M. Araake et al. // Antimicrob. Agents Chemother. 1996. — Vol. 40, № 6. — P. 1366−1370.
- Molecular mechanisms of aortic wall remodeling in response to hypertension / C. Xu, S. Lee, T.M. Singh et al. // J.Vase. Surg. — 2001.— Vol. 33.—P. 570—578.
- Mombouli, J.V. Endothelial function from physiology to therapy / J.V. Mombouli, P.M. Vanhoutte // J. Mol. Cell. Cardiol. 1999. — Vol. 31, № 1.-P. 61−74.
- Muhlestein, J.B. Antibiotic treatment of atherosclerosis / J.B. Muhlestein // Curr. Opin. Lipidol. 2003. — Vol. 14, N 6. — P. 605−614.
- Murphy, M.P. Nitric oxide and cell death / M.P. Murhy // Biochim. Biophys. Acta. 1999. — Vol. 404. — P. 249−252.
- NAD (P)H oxidase inhibition improves endothelial function in rat and human blood vessels / C.A. Hamilton, M.J. Brosnan, S. Al-Benna et al. // Hypertension. 2002. — Vol. 40. — P. 755−762.
- NAD (P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling / I.R. Hanna, Y. Taniyama, K. Szocs et al. // Antioxid Redox Signal. 2002. — Vol. 4, № 6. — P. 899−914.
- Napoli, C. Rethinking Primary Prevention of Atherosclerosis-Related Diseases / C. Napoli, L.O. Lerman, F. de Nigris // Circulation. 2006. — Vol. 114.-P. 2517−2527.
- Negative inotropic effects of cytokines on the heart mediated by nitric oxide / M.S. Finkel, C.V. Oddis, T.D. Jacob et al. // Science. 1992. — Vol. 257.-P. 387−389.
- Nicolau, D.P. Predicting antibacterial response from pharmacodynamic and pharmacokinetic profiles / D.P. Nicolau // Infection. — 2001. Vol. 29, Suppl. 2. — P. 11−15.
- Niebauer, J. NOS inhibitor accelerated atherogenesis: reversal by exersise / J. Niebauer, A.J. Maxwell, P. S. Lin // Am. J. Physiol. Heart. Circulat. Physiol. 2003. — Vol. 285. — P. H535-H540.
- Nilsen, O. Pharmacokinetics of macrolides / O. Nilsen // Infection, 1995. — Vol. 23, suppl. 1, — P. 5−9.
- Nilsson, I. Differential activation of vascular genes by hypoxia in primary endothelial cells / I. Nilsson, M. Shibuya, S. Wennstrom // Exp. Cell. Res. 2004. — Vol. 1, № 299. — P. 476−485.
- Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model / J.E. Shellito, J.K. Kolls, R. Olariu et al. // J. Infect. Dis. 1996. -Vol. 173.-P. 432−439.
- Nitric oxide as a signaling molecule in the vascular system: an overview / L.J. Jgnarro, G. Clrino, A. Casino et al. // J. Cardiolvasc. Pharmacol. 1999. — Vol. 34. — P. 879−886.
- Nitric oxide/cGMP protects endothelial cells from hypoxia-mediated leakiness / G.K. Kolluru, K.P. Tamilarasan, A.S. Rajkumar et al. // Eur. J. Cell. Biol. 2008. — Vol. 87, № 3. — P. 147−161. Epub. 2007, Nov 26.
- Niu, X.F. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils / X.F. Niu, C.W. Smith, P. Kubes // Circ Res. 1994. — Vol. 74. — P. 1133— 1140.
- No association between hepatitis C virus seropositivity and acute myocardial infarction / C.M. Arcari, K.E. Nelson, D.M. Netski et al. // Clin. Infect. Dis. 2006. — Vol. 43, N 6. — P. 53−56.
- NO synthase inhibition increases aldosterone in humans / J.A. Muldowney 3rd, S.N. Davis, D.E. Vaughan, N.J. Brown // Hypertension. 2004. — Vol. 44, № 5. — P. 739−745.
- Nussler, A.K. Inflamation, immunoregulation and inducible nitric oxide synthase / A.K. Nussler, T.R. Billiar // J. Biol. Chem. 1993. — Vol. 54.-P. 171−178.
- Okuda, K. Involvement of periodontopathic biofilm in vascular diseases / K. Okuda, K. Kato T. Ishihara // Oral Dis. 2004. — Vol. 10, N 1. -P. 5−12.
- Oral L-arginine improves endothelial dysfunction in patients with essential hypertension / J.P. Lekakis, S. Papathanassiou, T.G. Papaioannou et al. // Int. J. Cardiol. 2002. — Vol. 86. — P. 317−323.
- Ostergaard, L. Risk of cardio-vascular events in patients aged 50−70 years treated with macrolides versus periicillins / L. Ostergaard, H.T. Sorensen // Ibid. P. 421.
- Ou, Xue-Mei. Macrolides attenuate mucus hypersecretion in rat airways through inactivation of NF-kappa B / Xue-Mei Ou // Respirology. -2008.-Vol. 13, № 1. P. 63−72.
- Oupla, S. Chlamydia pneumoniae and coronary heart disease / S. Oupla, A. Camm//J. Br. Med. J. 1997.-Vol. 514.-P. 1778−1779.
- Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension / U. Landmesser, S. Dikalov, S.R. Price et al. // J. Clin. Invest. 2003. — Vol. 111. — P. 1201−1209.
- Pacher, P. Nitric oxide and peroxynitrite in health and disease / P. Pacher, J.S. Beckman, L. Liaudet // Physiol. Rev. 2007. — Vol 87. -P. 315−424.
- Palmer, R.M.J. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor / R.M.J. Palmer, A.G. Ferringe, S. Moncada // Nature. 1987. — Vol. 327. — P. 524— 526.
- Pamham, M.J. Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment / M.J. Pamham // Eur. J. Pharmacol. 2005. — Vol. 517, № 1—2. — P. 132—143.
- Parchure, N. Effect of azithromycin treatment on endothelial function in patients with coronary artery disease and evidence of Chlamydia pneumoniae infection / N. Parchure, E.G. Zouridakis, J.C. Kaski // Circulation.-2002.-Vol. 105, № n.p. 1298−1303.
- Parnham, M.J. Antibiotics, inflammation and its resolution: an overview / M.J. Parnaham // Antibiotics as anti-inflammatory and immunomodulatory agents / eds. B.K. Rubin, J. Tamaoki. Basel: Birk Verlag, 2004.-P. 27−48.
- Parnham, M.J. Immunomodulatory effects of antimicrobials in the therapy of respiratory tract infections / M.J. Parnham // Curr. Opin. Infect. Dis. 2005. — Vol. 18.-P. 125−131.
- Pasceri, V. Direct proinflammatoiy effect of C-reactive protein on human endothelial cells / V. Pasceri, J.T. Willerson, E.T. Yeh // Circulation. — 2000.-Vol. 102.-P. 2165—2168.
- Patel, P. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors / P. Patel, M.A. Mendall // Br. Med. J. 1995. — Vol. 311. — P. 711 714.
- Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals / T. Akaike, Y. Noguchi, S. Ijiri et al. // Proc. Natl. Acad. Sci. USA. -1996. Vol. 93. — P. 2448−2453.
- Pathophysiology of ischaemia-reperfusion injury / M. Sirotkovic-Skerlev, S. Plestina, I. Bilic, Z. Kovac // Lijec Vjesn. -2006. Vol. 128, № 3−4. — P. 87−95.
- Pathophysiology of pneumonia / S. Nelson, C.M. Mason, J. Kolls et al. // Clin. Chest. Med. 1995. — Vol. 16. — P. 1−12.
- Pechere, J.C. New perspectives on macrolide antibiotics / J.C. Pechere // Int. J. Antimicrob. Agents. 2001. — Vol. 18, Suppl 1. — P. S93−97.
- Pechere-Bertschi, A. Female sex hormones, salt, and blood pressure regulation / A. Pechere-Bertschi, M. Burnier // Am. J. Hypertens. 2004. -Vol. 17.-P. 994−1001.
- Peeling, R.W. Chlamydia as pathogens: new species and new issues / R.W. Peeling, R.C. Brunham // Emerging Infectious Diseases. 1996. -Vol. 2.-P. 307−319.
- Pepys, M.B. C-reactive protein: binding to lipids and lipoproteins / M.B. Pepys, I.F. Rowe, M.L. Baltz // Int. Rev. Exp. Pathol. 1985. — Vol. 27.-P. 83−111.
- Periodontal disease as a risk factor for ischemic stroke / AJ. Grau, H. Becher, C.M. Ziegler et al. // Stroke. 2004. — Vol. 35, № 2. -P. 496−501.
- Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST) / M. Desvarieux, R.T. Demmer, T. Rundek et al. // Circulation. 2005. -Vol. Ill, N5.-P. 576−582.
- Persistent Chlamydia pneumoniae Infection of Cardiomyocytes Is Correlated with Fatal Myocardial Infarction / L.G. Spagnoli, S. Pucci, E. Bonanno et al. // Am. J. Pathol. 2007. — Vol. 170. — P. 33−42.
- Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS / G.U. Meduri, S. Headley, G. Kohler et al. // Chest. 1995. — Vol. 107. -P. 1062−1073.
- Pharmacokinetic drug interactions of macrolides / P. Periti, T. Mazzei, E. Mini, A. Novell // Clin. Pharmacokinet. 1992. — Vol. 23, № 2. -P. 106−131.
- Physiology and biochemistry of endothelial function in children with chronic renal failure / J.A. Kan, A.T. Donald, D.T. Vallance el al. // Kidney. Intern. 1997. — Vol. 52. — P. 468—472.
- Plasma antioxidant potential in severe sepsis: A comparison of survival and nonsurvival / H.C. Cowley, P.J. Bacon, H.F. Good et al. // Crit. Care. Med. 1996. — Vol. 24. — P. 1179−1183.
- Plewig, G. Anti-inflammatory effects of antimicrobial agents: an in vivo study/ G. Plewig, E. Schopf // J. Invest. Dermatology. -1975. Vol. 65. — P. 532−536.
- Popovic, M. Molecules. Antioxidant effects of some drugs on ethanol-induced ulcers / M. Popovic, S. Janicijevic-Hudomal, B. Kaurinovic // Clin. Pharmacokinet. 2009. — Vol. 14, № 2. — P. 816−826.
- Potential effects of eiythromycin on host defense systems and virulence of P. aeruginosa. Antimicrob / Y. Hirakata, M. Kaku, R. Mizukane et al. // Ag. Chemother. 1992. — Vol. 36. — P. 1922−1927.
- Potential infectious etiologies of atherosclerosis: a multifactorial perspective / S. O’Connor, C. Taylor, L.A. Campbell et al. // Emerg. Infect. Dis. 2001. — Vol. 7, N 5. — P. 780−788.
- Preconditioning ischemia attenuates molecular indices of platelet activation-aggregation / M.D. Linden, P. Whittaker, A.L. Frelinger 3rd et al. // J. Thromb. Haemost. 2006. — Vol. 4, № 12.- P. 2670−2678.
- Predisposition to atherosclerosis by infections: role of endothelial dysfunction / A. Prasad, J. Zhu, J.P. Halcox et al. // Circulation. 2002. -Vol. 106, N 2.-P. 184−190.
- Prospective study of Chlamydia pneumoniae IgG seropositivity and risks offuture myocardial infarction / P.M. Ridker, R.B. Kundsin, M.J. Stampfer et al. // Circulation. 1999. — Vol. 99. — P. 1161−1164.
- Prospective survey of antibiotic utilization in pediatric hospitalized patients to identify targets for improvement of prescription / M. Potocki, J. Goette, T.D. Szucs, D. Nadal // Infection.- 2003. Vol. 31, № 6. — P. 398−403.
- Protection of azithromycin against pulmonary II epithelial cell injuries induced by cigarette smoke extract and relevant mechanisms / X.R. Zhang, L.K. Duo, P.R. Xu et al. // Zhongguo Dang Dai Er Ke Za Zhi. 2007. -Vol. 9, № 1. — P. 63−66.
- Protective role of nitric oxide in Staphylococcus aureus infection in mice / S. Sasaki, T. Miura, S. Nishikawa et al. // Infect. Immun. 1998. — Vol. 66. — P. 1017−1022.
- Quach, C. Acute otitis media in children: a retrospective analysis of physician prescribing patterns / C. Quach, J.P. Collet, J. LeLorier // Br. J. Clin. Pharmacol. 2004. — Vol. 57, № 4. — P. 500 505.
- Quinn, T.C. In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells / T.C. Quinn, C.A. Gaydos // Am. Heart J. 1999.-Vol. 138. — P. 507−511.
- Rabbit model for Chlamydia pneumoniae infection / I.W. Fong, B. Chiu, E. Viira et al. // J. Clin. Microb. 1997. — Vol. 35. — P. 48−52.
- Rabelink, T.J. Endothelial Nitric Oxide Synthase Host Defense Enzyme of the Endothelium? / T.J. Rabelink, T.F. Luscher // Arteriosclerosis, Thrombosis, and Vascular Biology. 2006. — Vol. 26. — P. 267−271.
- Rader, D.J. Inflammatory markers of coronary risk / D.J. Rader // New Engl. J. Med. 2000. — Vol. 343. — P. 1179.
- Ramirez, J. Atherosclerosis Study Group. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis / J. Ramirez // Ann. Intern. Med. 1996. — Vol. 125. -P. 979−982.
- J. Anderson, J.B. Muhlestein, J. Carlquist et al. I I Circulation. 1999. -Vol. 99.-P. 1540−1547.
- Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study / J.B. Muhlestein, J.L. Anderson, J.F. Carlquist et al. // Circulation. -2000. Vol. 102. — P. 1755−1760.
- Randomized trial of roxythromycin in non-Q-wave coronary syndromes: ROXIS pilot study / E. Gurfinkel, G. Bozovich, A. Daroca et al. // Lancet. 1997. — Vol. 350. — P. 404−407.
- Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-alpha is mediated by ceramide / S. Corda, C. Laplace, E. Vicaut et al. // Am. J. Respir. Cell. Mol. Biol. 2001. — Vol. 24. — P. 762−768.
- Ras, G. An in-vitro study of oral therapeutic doses of co-trimoxazole and eiythromycin stearate on abnormal polymorphonuclear leucocyte migration/G. Ras, R. Anderson // J. Antimicrob. Chemother. 1996. -Vol.17.-P. 185−193.
- Rasmussen, S.J. PCR detection and differentiation of Chlamydia pneumoniae, Chlamydia psittaci and Chlamydia trachomatis (abstract) /
- J. Rasmussen, F.P. Douglas, P. Timms // Mol. Cell. Probos. 1992. — Vol.6.-P. 389−394.
- Recio-Mayoral, A. Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease / A. Recio-Mayoral, J.C. Mason, J.C. Kaski // Eur. Heart J. 2009. — Vol. 30, № 15. — P. 1837 — 1843.
- Regression of atherosclerosis: role of nitric oxide and apoptosis / B.Y. Wang, H.K. Ho, P. Lin et al. // Circulation. 1999. — Vol. 99. — P. 1236—1241.
- Regulatory role of arginase I and II in nitric oxide, polyatnine and proline synthesis in endothelial cells / F.F. Li, C.J. Meininger, J.R. Hawkerel al. // Am. J. Physiol. Endocrmol. Metab. 2001. — Vol. 280. — P. E75— E82.
- Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes / C.J. Boos, S.K. Soor, D. Kang, G.Y. Lip // Eur. Heart. J. 2007. — Vol. 28, № 9. — P. 1092−1101. Epub 2007 Apr 21.
- Release of nitric oxide and expression of constitutive nitric oxide synthetase of human endothelial cells: enhancement by a 14-membered ring macrolide / T. Mitsuyama, K. Hidaka, T. Furuno, N. Hara // Mol. Cell. Biochem.-1998.-Vol. 181.-P. 157−161.
- Renin-Angiotensin System Modulates Oxidative Stress-Induced Endothelial Cell Apoptosis in Rats Hypertension / M. Akishita, K. Nagai,
- H. Xi et al. // Hypertension. 2005. — Vol. 45, № 6. — P. 1188 — 1193.
- Requirement for transcription factor IRF-1 in NO synthase induction in macrophages / R. Kamijo, H. Harada, T. Matsuyama et al. // Science. 1994. — Vol. 263.-P. 1612−1615.
- Resident cardiac mast cells degranulate and release preformed TNF, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion / N. Frangogiannis, M. Lindsey, L. Michael et al. // Circulation. 1998. — Vol. 97. — P. 699−710
- Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase / T. Yamashita, S. Kawashima, Y. Ohashi et al. // J. Circulation. 2000. — Vol.101, N8. — P. 931−937.
- Retsema, J. Macrolides: structures and microbial targets / J. Retsema, W. Fu // Int. J. Antimicrob. Agents. 2001. — Vol. 18, Suppl.1. P. S3-S10.
- Ridker, P.M. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men / P.M. Ridker, P. Cushman, MJ. Stampfer // N. Engl. J. Med. 1997. — Vol. 336. — P. 973−979.
- Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination / L. Smeeth, S. L. Thomas, A. J. Hall et al. // N. Engl. J. Med. -2004. Vol. 351, № 25. — P. 2611 — 2618.
- Roivainen, M. Enteroviruses and myocardial infarction / M. Roivainen // Am. Heart. J. 1999. — Vol. 138, № 5, Pt 2. — P. S479−483.
- Role of endothelin in the stimulation of NAD (P)H oxydase and superoxyde production in vascular smooth muscle cells following a treatment with angiotensin II / M. Laplante., R. Wu, P. Moreau et al. // J. Hypertension. 2003. — Vol. 2, № 4. — P. 200.
- Role of innate and adaptive immunity in the outcome of primaiy infection with Chlamydia pneumoniae, as analyzed in genetically modified mice / M.E. Rottenberg, A.C. Gigliotti Rothfuchs, D. Gigliotti et al. // J. Immunol. 1999. -Vol. 162.-P. 2829−2836.
- Role of interleukin-8 (IL-8) and an inhibitory effect of eiythromycin on IL-8 release in the airways of patients with chronic airway diseases / K. Oishi, F. Sonoda, S. Kobayashi et al. // Infection Immunity. 1994. -Vol. 62.-P. 4145−4152.
- Role of phospholipase D-derived diradylglycerol in the activation of the muan neutrophil respiratory burst oxidase / D. Perry, W. Hand, D. Edmondson et al. // J. Immunol. 1992. — Vol. 149. -P. 2749−2758.
- Rota, S. Mycobacterium tuberculosis complex in atherosclerosis / S. Rota // Acta Med. Okayama. 2005. — Vol. 59, N 6. — P. 247−251.
- Roxithromycin supresses mucin gene expression in epithelial cells / D.Y. Kim, K. Takeuchi, H. Ishinaga et al. // Pharmacology. 2004. -Vol. 72.-P. 6−11.
- Rueckschloss, U. NADPH oxidase in endothelial cells: impact on atherosclerosis / U. Rueckschloss, N. Duerrschmidt, H. Morawietz // Antioxid. Redox. Signal. 2003. — Vol. 5, № 2. — P. 171−180.
- Rus, H.G. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall / H.G. Rus, R. Vlaicu, F. Niculescu // Atherosclerosis. 1996. — Vol. 127. — P. 263−271.
- Rush, J.W. Vascular biology of angiotensin and the impact of physical activity / J.W. Rush, C.D. Aultman // Appl. Physiol. Nutr. Metab. 2008. -Vol. 33, № l.-P. 162−172. AT2.
- Ruuskanen, O. Safety and tolerability of azithromycin in pediatric infectious diseases: 2003 update O. Ruuskanen // Pediatr. Infect. Dis. J. — 2004. — Vol. 23, 2 Suppl. — P. 135—139.
- Saikku, P. Chlamidia pneumoniae and cardiovascular disease / P. Saikku // Clin. Microbiol. Infect. 1996. — Vol. 1 (suppl. 1). — P. 19−22.
- Saikku, P. Chlamydia pneumoniae and artherosclerosis an update / P. Saikku // Scan J. Infect Dis. 1997. — Vol. 104 (Suppl.). — P. 53−56.
- Saikku, P. Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction / P. Saikku // Eur. Heart. J. 1993. — Vol. 14. — P. 6265.
- Saikku, P. Chronic Chlamydia pneumoniae infections / P. Saikku // Abstracts of Proceedings of the 3rd Meeting of the European Society for Chlamydial Research. P.215−218.
- Sander, D. Reduced Progression of Early Carotid Atherosclerosis After Antibiotic Treatment and Chlamydia pneumoniae Seropositivity / D. Sander, K. Winbeck, J. Klingelhofer // Circulation. 2002. — Vol. 106. -P. 2428 -2433.
- Sanz, M.J. Erythromycin exerts in vivo anti-inflammatory activity downregulating cell adhesion molecule expression / M.J. Sanz, Y.N. Nabah, M. Cerda-Nicolas // Br. J. Pharmacol. 2005. -Vol. 144.-P. 190−201.
- Scaglione, F. Comparative anti-inflammatory effect of roxithromycin, azithromycin and clarithromycin. 3rd Int. Conf. on the Macrolides, Azalides and Streptogramins / F. Scaglione, G.Rossini. Lisbon. — 1996. — P.73.
- Scaglione, F. Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin / F. Scaglione // J. Antimicrob Chemother.-1998. Vol. 41. — Suppl B. — P.47−50.
- Schini, V.B. Indapamide potentiates the endothelium-depend relaxation in isolated canine femoral arteries / V.B. Schini, J. Dewey, P.M. Vanhoutte // Am. J. Card. 1990. — Vol. 65, № 17. — P. 6H-10H.
- Schmieder, R.E. Endothelial dysfunction: how can one intervene at the beginning of the cardiovascular continuum / R.E. Schmieder // J. Hypertens. 2006. — Vol. 24(2). — P. 31−35.
- Scholtz, J. Management of acne vulgaris/ J. Scholtz // Rational Drug Therapy. 1977. — Vol. 11. — P. 1−6.
- Schroeder, R.A. CD14-dependent mechanism for endotoxin-mediated nitric oxide synthesis in murine macrophages / R.A. Schroeder, A. delaTorre, P.C. Kuo // American Journal Of Physiology Cell Physiology. 1997. — Vol. 42, № 3. — P. C1030-C1039.
- Serial studies of leukocyte chemiluminescence: lack of effect of macrolide antibiotic therapy/ R. Martin, M. Putman, S. Greenberg et al. // J. Med. 1980. — Vol. 11. — P. 39−48.
- Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction / P. Saikku, M. Leinonen, K. Mattila et al. // Lancet. 1988. — Vol. 2, № 8618.-P. 983−986.
- Sharma, S. Immunomodulatory effects of macrolide antibiotics in respiratory disease: therapeutic implications for asthma and cystic fibrosis / S. Sharma // Paediatr Drugs.-2007.-Vol.9,№ 2.-P. 107−118.
- Shecher, I. The metabolism of native and malondialdehyde-altered low density lipoprotens by humen monocyte-macrophages / I. Shecher,
- A.M. Fogelman, M.E.Hoberland // J. Lipid. Res. 1981. — Vol. 22, № 1. -P. 63−71.
- Shirai, T. Effect of 14-membered ring macrolide therapy on chronic respiratory tract infections and polymorphonuclear leukocyte activity / T. Shirai, A. Sato, K. Chida / Int. Med. 1995. — Vol. 34. — P. 469−474.
- Significant survival benefit to patients with advanced non-small-cell lung cancer from treatment with clarithromycin / K. Mikasa, M. Sawaki, E. Kita et al. // Chemotherapy. 1997. — Vol. 43. -P. 288−296.
- Smeeth, L. Risk of myocardial infarction and stroke after acute infection or vaccination / L. Smeeth, S.L. Thomas, A.J. Hall // N Engl J Med. 2004. — Vol. 351. — P. 2611−2618.
- Smeeth, L. The role of infection in cardiovascular disease: more support but many questions remain / L. Smeeth, J.P. Casas, A.D. Hingorani // Eur. Heart J. 2007. — Vol. 28, № 10. — P. 1178−1179.
- Smith, A.W. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? / A.W. Smith // Adv. Drug Deliv. Rev. 2005. — Vol. 57, N 10. — P. 15 391 550.
- Song, J. Androgens augment renal vascular responses to ANG II in New Zealand genetically hypertensive rats / J. Song, C.K. Kost Jr, D.S. Martin // Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006. — Vol. 290, № 6. — P. 1608−1615. Epub 2006 Feb 9.
- Song, Z. A meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseases / Z. Song, P. Brassard, J.M. Brophy // Can. J. Cardiol. 2008. — Vol. 24, № 5. — P. 391−395.
- Specificity of detection of Chlamydia pneumoniae in cardiovascular ather-oma: Evaluation of the innocent bystander hypothesis / L.A. Jackson, L.A. Campbell, R.A. Schmidt et al. // Am. J. Pathol. 1997. — Vol. 150. -P.1785−1790.
- Spector, S. Troleandomycin: effectiveness in steroid-dependent asthma and bronchitis/ S. Spector, F. Katz, R. Fan // J. Allergy Clin. Immunol.- 1974.-Vol. 54.-P. 367−379.
- Spillmann, F. Cardioprotective mechanisms of the kallikrein-kinin system in diabetic cardiopathy / F. Spillmann, S. Van Linthout, H.P. Schultheisshope // Curr. Opin. Nephrol. Hypertens. 2006. — Vol. 15, № 1.- P. 22−29.
- Spink, J. Binding of the transcription factor interferon regulatoiy factor-1 to the inducible nitric-oxide synthase promoter / J. Spink, T.J. Evans // Biol. Chem. -1997.- Vol.272.-P. 24 417−24 425.
- Sponk, P.E. Bench-to-bedside review: sepsis is a disease of the microcirculation / P.E. Sponk, D.F. Zandstra, C. Ince // Critical Care.-2004.-Vol. 8. P. 462−468.
- Stimulation of interleukin-1 and tumor necrosis factor produciton by oral eiythromycin / J. Katahira, K. Haruki, Y. Shibata et al. // Chemotherapy (Tokyo). 1991. — Vol. 39. — P. 320−328.
- Study on azithromycin in treatment of diffuse panbronchiolitis. 3rd Int. Conf. on the Macrolides, Azalides and Streptogramins /
- H. Kobayashi, K. Shimada, K. Nakata, H. Ootami. Lisbon, 1996. — P. 75.
- Suez, D. Excessive accumulation of mucus in children with asthma: a potential role for erythromycin A case discussion / D. Suez, S. Szefler // J. Allergy Clin. Immunol. 1986. — Vol. 77. — P. 330−334.
- Sugiyama, Y. Cytokines production from alveolar macrophages of rats fed by long term, low dose erythromycin. In: European Respiratory Society / Y. Sugiyama, S. Kitamura, T. Kasahara // Annual Congress. Berlin. 1997. -abstr. P. 432.
- Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro / K. Kanai, K. Asano, T. Hisamitsu, H. Suzaki // Eur Respir J. 2004. — Vol. 23.-P. 671−678.
- Sutter, M.C. Lessons for atherosclerosis research from tuberculosis and peptic ulcer / M.C. Sutter // CMAJ. 1995. — Vol. 152, № 5. — P. 667 670.
- Sutton, J.A. prediction rule for left ventricular dilatation post-MI? / J. Sutton, C.N. Scott // Eur. Heart J. 2002. — Vol. 23. — P. 509−511.
- Taha, M.K. Neisseria meningitidis induces the expression of the TNF-alpha gene in endothelial cells / M.K. Taha // J. Cytokine. 2000. — Vol.12, N1.-P. 21−25.
- Takashi, I. Clarithromycin Inhibits NF-kB Activation in Human Peripheral Blood Mononuclear Cells and Pulmonary Epithelial Cells /
- Takashi // Antimicrobial Agents and Chemotherapy. 2001. — Vol. 45, № 1. — P. 44−47.
- Tamaoki, J. Clinical implications of the immunomodulatoiy effects of macrolides / J. Tamaoki, J. Kadota, H. Takizawa // Am. J. Med. 2004. — Vol. 117 (Suppl. 9A). — P.5S-11S.
- Taniyama, Y. Reactive oxygen species in the vasculature: molecular and cellular mechanisms / Y. Taniyama, K.K. Griendling // Hypertension. — 2003.—Vol. 42, N6.-P. 1075—1081.
- Taylor-Robinson, D. The failure of antibiotics to prevent heart attacks / D. Taylor-Robinson, J. Boman // BMJ. 2005. — Vol. 331. — P. 361−362.
- Tentolouris, C. L-arginine «paradox» in coronary atherosclerosis / C. Tentolouris, D. Tousoulis, C. Stefanadis // Circulation. 2004. -Vol. 110, № 7. — P. 71.
- The anti-inflammatory effect of eiythromycin in zymosan-induced peritonitis of mice / K. Mikasa, E. Kita, M. Sawaki et al. // J. Antimicrob. Chemother. 1992. — Vol. 30. — P. 339−348.
- The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data / I. Basyigit, R. Yildiz, S. Ozkara et al. // Ann. Pharmacother. -2004.-Vol. 38,№ 9.-P. 1400−1405.
- The effect of short-term treatment with azithromycin on recurrent ischemic events in patients with acute coronary syndromes / B. Cercek, P.K. Shah, M. Noc et al. //Lancet. -2001. Vol. 361. — P. 809−813.
- The Infectious Etiology of Chronic Diseases: Defining the Relationship, Enhancing the Research, and Mitigating the Effects / eds. L.K. Stacey, S.M. Lemon, M. Najafi. -Washington, D.C.: The National Academic Press, 2004. 215 p.
- The role of infection in cardiovascular disease: more support but many questions remain / L. Smeeth, J.P. Casas, A.D. Hingorani et al. // Eur. Heart J. -2007.- Vol.28,№ 10.-P. 1178−1179.
- Tissue factor antigen and activity in human coronary atherosclerotic plaques / D. Ardissino, P.A. Merlini, R. Ariens et al. // Lancet. 1997. -Vol. 349.-P. 769−771.
- Tissue factor modulates the thrombogenecity of human atherosclerotic plaques / V. Toschi, R. Gallo, M. Lettino et al. // Circulation. 1997. — Vol. 95.-P. 594−599.
- Tohru, Kikuchi. Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kB transcription factors / Kikuchi Tohru // Journal of Antimicrobial Chemotherapy. -2002. Vol. 49. — P. 745−755.
- Touyz, R.M. Oxidative stress and vascular damage in hypertension / R.M. Touyz // Curr. Hypertens. Rep. 2000. — Vol. 2, № 1. — P. 98−105.
- Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima-media thickness / S. Piconi, D. Trabattoni, C. Luraghi et al. // FASEB J. 2009. — Vol. 23, № 4. p. 1196- 1204.
- Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes: The final report of the ROXIS study / E. Gurfinkel, G. Bozovich, E. Beck et al. // Europ. Heart J. 1999. — Vol. 20. -P. 121−127.
- Tschudi, M.R. Nitric oxide: the endogenous nitrate in the cardiovascular system/M.R. Tschudi, T.F. Luscher//Herz.- 1996. Vol. 21.-P.50−60.
- Ulevitch, R.J. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin / R.J. Ulevitch, P. S. Tobias // Annu. Rev. Immunol. 1995. -Vol. 13.-P. 437−457.
- Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors / U. Laufs, F. La, J. Plutzky, J.K. Liao // Circulation. -1998.-Vol. 97.-P. 1129−1135.
- Vallance, P. Infection, inflammation and infarction: does acute endothelial dysfunction provide a link? / P. Vallance, J. Collier, K. Bhagat // Lancet. 1997. — Vol. 349. — P. 1391−1392.
- Vascular effects of nitric oxide are opposed by increased production of free radicals in diabetic rats / D. Diederich, J. Skopec, A. Diederich et al. // Ophthalmic. Researches. EVER-1999 Abstacts. 1999. Vol.31. — P.228−231.
- Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes / Y.K. Kim, M.S. Lee, S.M. Son et al. // Diabetes. -2002. Vol. 51. -P. 522−527.
- Vaudaux, B.P. Tonsillar adenoid tissue concentracions of azitromycin / B.P. Vaudaux // The 3rd International Conferens on the macrolides, Azalides, and Streptogramins. 1996. — abstr. 4. — P. 12.
- Vermeersch, P. L-arginine administration reduces neointima formation after stent injury in rats by a nitric oxide-mediated mechanism / P. Vermeersch, Z. Nong, E. Stabile // Arterioscler. Thromb. Vase. Biol. -2001.-Vol. 21.-P. 1604−1615.
- Vincent, J.-L. Microvascular dysfunction as a cause of organ dysfunction in severe sepsis / J.-L. Vincent, D. De Backer // Critical Care. -2005. Vol. 9. -No. 4. — P. s.9-s.l2.
- Virchow, R. Der atheromatose prozess der arterien / R. Virchow // Wien. Med. Wochenschr. 1856. — Vol. 6. — P. 809−812, 825−827.
- Viruses induced atherosclerosis / C.G. Fabricant, J. Fabricant, M.M. Litrenta et al. // J. Exp. Med. 1978. — Vol. 148. — P. 335−340.
- Vladimirova-Kitova, LG. Asymmetric dimethylarginine—mechanisms and targets for therapeutic management / L.G. Vladimirova-Kitova // Folia. Med. (Plovdiv). 2008. — Vol. 50, № 1. — P. 12−21.
- Volanakis, J.E. Complement activation by C-reactive protein complexes / J.E. Volanakis // Ann. N Y Acad. Sci. 1982. — Vol. 389. -P. 235−250.
- Wallwork, B. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis / B. Wallwork // Laryngoscope. 2006. — Vol. 116, № 2.-P. 189−193.
- Walsh, M.P. Marshall The early effects of chronic hypoxia on the cardiovascular system in the rat: role of nitric oxide / M.P. Walsh, J. M. Marshall // J. Physiol. 2006. — Vol. 575, № 1. — P. 263−275.
- Walter, R. L-arginine influences human whole blood viscosity independent of nitric oxide synthase activity in vitro / R. Walter, M. Mark, W.H. Reinhart // Biochem. Biophys. Res. Commun. 2000. — Vol. 269. -P. 687- 691.
- Wang, D. Macrolide Antibiotics Aggravate Experimental Autoimmune Encephalomyelitis and Inhibit Inducible Nitric Oxide Synthase / D. Wahg // Immunological Investigations. 2009. — Vol. 38, № 7. — P. 602−612.
- Webber, M.A. The importance of efflux pumps in bacterial antibiotic resistance / M.A. Webber, L.J.V. Piddock // J. Antimicrob. Chemother. -2003.-Vol. 51, N 1.-P. 9−11.
- Weib, B. Chlamydia pneumonia infection alters gene expression in endotelial cells / B. Weib, F.N. Wuppermann // Ibid. 2004. — P. 297.
- Weis, M. Cardiac Allograft Vasculopathy and Dysregulation of the NO Synthase Pathway / M. Weis, J.P. Cooke // Arterioscler. Thromb. Vase. Biol. 2003. — Vol. 23, № 4. — P. 567−575.
- Wong, B. The ACES Investigators, the PROVE IT-TIMI 22 Investigators. Chlamydia pneumoniae and Acute Coronary Syndrome / B. Wong, Y.L. Gnarpe, J. Mitchell //NEJM-2005.-Vol. 353.-P. 525−528.
- Wyatt, A.W. Modulation of the L-arginine/nitric oxide signalling pathway in vascular endothelial cells / A.W. Wyatt // Biochem. Soc. Symp. 2004. — Vol. 71. -P. 143−156.
- Xia, Y. Superoxide generation from endothelial nitric-oxide synthase / Y. Xia, A. L. Tsai, V. Berka//J. Biol. Chem -1998. Vol. 273. -P. 25 804−25 808.
- Xue-Mei, O.U. Macrolides attenuate mucus hypersecretion in rat airways through inactivation of NF-Kb / O.U. Xue-Mei // Respirology. -2008.- Vol. 11, Issue 1.-P. 63−72.
- Yoshiyuki, Kyo. Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice / Kyo Yoshiyuki // Mediators of Inflammation. -2003. Vol. 12, N. 4. -P. 195−202.
- Yukiko, lino. Effect of macrolides on the expression of human leukocyte antigen-DR and costimulatory molecules on cultured human mononuclear cells / lino Yukiko // Allergology International. 2008. -Vol. 50, Issue 1. -P.73−80.
- Zamora, R. Inducible nitric oxide synthase and inflammatory diseases / R. Zamora, V. Vodovotz, T.R. Billiar // Molec. Med. 2000. — Vol. 6, N 5. — P. 347−373.
- Zewde, T. Influence of dietary NaCl on L-arginine transport in the renal medulla / T. Zewde, F. Wu, D.L. Mattson // Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004. — Vol. 286, № 1. — P. R89−93.
- Zhang, H. Role of TNF-alpha in vascular dysfunction / H. Zhang, Y. Park, J. Wu // Clin. Sei. 2009. — Vol. 116, № 3. — P. 219−230.